<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34997540</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>06</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>3</Issue><PubDate><Year>2022</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.</ArticleTitle><Pagination><StartPage>1502</StartPage><EndPage>1527</EndPage><MedlinePgn>1502-1527</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-021-02658-6</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a fatal neurological disorder characterized by progressive degeneration of motor neurons leading to skeletal muscle denervation. Earlier studies have shown that motor neuron degeneration begins in motor cortex and descends to the neuromuscular junction (NMJ) in a dying forward fashion. However, accumulating evidences support that ALS is a distal axonopathy where early pathological changes occur at the NMJ, prior to onset of clinical symptoms and propagates towards the motor neuron cell body supporting "dying back" hypothesis. Despite several evidences, series of events triggering NMJ disassembly in ALS are still obscure. Neuromuscular junction is a specialized tripartite chemical synapse which involves a well-coordinated communication among the presynaptic motor neuron, postsynaptic skeletal muscle, and terminal Schwann cells. This review provides comprehensive insight into the role of NMJ in ALS pathogenesis. We have emphasized the molecular alterations in cellular components of NMJ leading to loss of effective neuromuscular transmission in ALS. Further, we provide a preview into research involved in exploring NMJ as potential target for designing effective therapies for ALS.</AbstractText><CopyrightInformation>&#xa9; 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Verma</LastName><ForeName>Sagar</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Research, Sir Ganga Ram Hospital, Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biotechnology, Jamia Hamdard, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khurana</LastName><ForeName>Shiffali</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Research, Sir Ganga Ram Hospital, Delhi, India.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biomedical Science, Bhaskaracharya College of Applied Sciences, University of Delhi, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vats</LastName><ForeName>Abhishek</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Ophthalmology, School of Medicine, University of Pittsburgh, Pittsburgh, PA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sahu</LastName><ForeName>Bandana</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Research, Sir Ganga Ram Hospital, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganguly</LastName><ForeName>Nirmal Kumar</ForeName><Initials>NK</Initials><AffiliationInfo><Affiliation>Department of Research, Sir Ganga Ram Hospital, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chakraborti</LastName><ForeName>Pradip</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, Jamia Hamdard, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gourie-Devi</LastName><ForeName>Mandaville</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurophysiology, Sir Ganga Ram Hospital, Delhi, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Taneja</LastName><ForeName>Vibha</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0001-5457-9992</Identifier><AffiliationInfo><Affiliation>Department of Research, Sir Ganga Ram Hospital, Delhi, India. vibha.taneja@sgrh.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>09/591(0150)/2018-EMR-I</GrantID><Agency>council&#xa0;of&#xa0;scientific and industrial research, india</Agency><Country/></Grant><Grant><GrantID>BMS/Adhoc/BIOCHEM/2015-0430</GrantID><Agency>indian council of medical research</Agency><Country/></Grant><Grant><GrantID>3/1/3/JRF-2012/HRD</GrantID><Agency>indian council of medical research</Agency><Country/></Grant><Grant><GrantID>BIC/05 (09)/Indo-Russian/2016</GrantID><Agency>indian council of medical research</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018482" MajorTopicYN="N">Muscle, Skeletal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013569" MajorTopicYN="N">Synapses</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Dying back</Keyword><Keyword MajorTopicYN="N">Motor neuron</Keyword><Keyword MajorTopicYN="N">Neuromuscular junction</Keyword><Keyword MajorTopicYN="N">Skeletal muscle</Keyword><Keyword MajorTopicYN="N">Terminal Schwann cells</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>11</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34997540</ArticleId><ArticleId IdType="doi">10.1007/s12035-021-02658-6</ArticleId><ArticleId IdType="pii">10.1007/s12035-021-02658-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nalini A, Thennarasu K, Gourie-Devi M, Shenoy S, Kulshreshtha D (2008) Clinical characteristics and survival pattern of 1153 patients with amyotrophic lateral sclerosis: experience over 30 years from India. J Neurol Sci 272(1&#x2013;2):60&#x2013;70. https://doi.org/10.1016/j.jns.2008.04.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2008.04.034</ArticleId><ArticleId IdType="pubmed">18550082</ArticleId></ArticleIdList></Reference><Reference><Citation>Pupillo E, Messina P, Logroscino G, Beghi E, SLALOM Group (2014) Long-term survival in amyotrophic lateral sclerosis: a population-based study. Ann Neurol 75(2):287&#x2013;297. https://doi.org/10.1002/ana.24096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24096</ArticleId><ArticleId IdType="pubmed">24382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Moura MC, Novaes MRCG, Eduardo EJ, Zago YSSP, Freitas RDNB, Casulari LA (2015) Prognostic factors in amyotrophic lateral sclerosis: a population-based study. PLoS One 10(10):e0141500. https://doi.org/10.1371/journal.pone.0141500</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0141500</ArticleId><ArticleId IdType="pubmed">26517122</ArticleId><ArticleId IdType="pmc">4627754</ArticleId></ArticleIdList></Reference><Reference><Citation>Knibb JA, Keren N, Kulka A, Leigh PN, Martin S, Shaw CE, Tsuda M, Al-Chalabi A (2016) A clinical tool for predicting survival in ALS. J Neurol Neurosurg Psychiatry 87(12):1361&#x2013;1367. https://doi.org/10.1136/jnnp-2015-312908</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312908</ArticleId><ArticleId IdType="pubmed">27378085</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats A, Gourie-Devi M, Verma M, Ramachandran S, Taneja B, Kukreti R, Taneja V (2016) Identification of L84F mutation with a novel nucleotide change c.255G &gt; T in the superoxide dismutase gene in a North Indian Family with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener 17(3&#x2013;4):253&#x2013;259. https://doi.org/10.3109/21678421.2015.1111906</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1111906</ArticleId><ArticleId IdType="pubmed">26630559</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Chi&#xf2; A, Traynor BJ (2014) State of play in amyotrophic lateral sclerosis genetics. Nat Neurosci 17(1):17&#x2013;23. https://doi.org/10.1038/nn.3584</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3584</ArticleId><ArticleId IdType="pubmed">24369373</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulder DW, Lambert EH, Eaton LM (1959) Myasthenic syndrome in patients with amyotrophic lateral sclerosis. Neurology 9:627&#x2013;631. https://doi.org/10.1212/wnl.9.10.627</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.9.10.627</ArticleId><ArticleId IdType="pubmed">14425103</ArticleId></ArticleIdList></Reference><Reference><Citation>Killian JM, Wilfong AA, Burnett L, Appel SH, Boland D (1994) Decremental motor responses to repetitive nerve stimulation in ALS. Muscle Nerve 17(7):747&#x2013;754. https://doi.org/10.1002/mus.880170708</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880170708</ArticleId><ArticleId IdType="pubmed">8008001</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu F, Jin J, Kang L, Jia R, Qin X, Liu X, Liu X, Liu C et al (2018) Decremental responses to repetitive nerve stimulation in amyotrophic lateral sclerosis. Eur Neurol 80(3&#x2013;4):151&#x2013;156. https://doi.org/10.1159/000494670</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000494670</ArticleId><ArticleId IdType="pubmed">30463071</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang L, Chu H, Lu Z (2020) Can the Large-Scale Decrement in repetitive nerve stimulation be used as an exclusion criterion for amyotrophic lateral sclerosis? Front Neurol 11:101. https://doi.org/10.3389/fneur.2020.00101</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00101</ArticleId><ArticleId IdType="pubmed">32184752</ArticleId><ArticleId IdType="pmc">7059024</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen EC, Olney RK (1997) Longitudinal study of fiber density and motor unit number estimate in patients with amyotrophic lateral sclerosis. Neurology 49(2):573&#x2013;578. https://doi.org/10.1212/wnl.49.2.573</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.49.2.573</ArticleId><ArticleId IdType="pubmed">9270599</ArticleId></ArticleIdList></Reference><Reference><Citation>van Dijk JP, Schelhaas HJ, Van Schaik IN, Janssen HMHA, Stegeman DF, Zwarts MJ (2010) Monitoring disease progression using high-density motor unit number estimation in amyotrophic lateral sclerosis. Muscle Nerve 42(2):239&#x2013;244. https://doi.org/10.1002/mus.21680</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.21680</ArticleId><ArticleId IdType="pubmed">20544934</ArticleId></ArticleIdList></Reference><Reference><Citation>Shefner JM, Watson ML, Simionescu L, Caress JB, Burns TM, Maragakis NJ, Benatar M, David WS et al (2011) Multipoint incremental motor unit number estimation as an outcome measure in ALS. Neurology 77(3):235&#x2013;241. https://doi.org/10.1212/WNL.0b013e318225aabf</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e318225aabf</ArticleId><ArticleId IdType="pubmed">21676915</ArticleId><ArticleId IdType="pmc">3136054</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiernan MC, Vucic S, Cheah BC, Turner MR, Eisen A, Hardiman O, Burrell JR, Zoing MC (2011) Amyotrophic lateral sclerosis. Lancet 377(9769):942&#x2013;955. https://doi.org/10.1016/S0140-6736(10)61156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(10)61156-7</ArticleId><ArticleId IdType="pubmed">21296405</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Nicholson GA, Kiernan MC (2008) Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis. Brain 131(Pt6):1540&#x2013;1550. https://doi.org/10.1093/brain/awn071</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn071</ArticleId><ArticleId IdType="pubmed">18469020</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S (2015) Cortical hyperexcitability precedes lower motor neuron dysfunction in ALS. Clin Neurophysiol 126(4):803&#x2013;809. https://doi.org/10.1016/j.clinph.2014.04.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2014.04.023</ArticleId><ArticleId IdType="pubmed">25227219</ArticleId></ArticleIdList></Reference><Reference><Citation>Blizzard CA, Southam KA, Dawkins E, Lewis KE, King AE, Clark JA, Dickson TC (2015) Identifying the primary site of pathogenesis in amyotrophic lateral sclerosis - vulnerability of lower motor neurons to proximal excitotoxicity. Dis Model Mech 8(3):215&#x2013;224. https://doi.org/10.1242/dmm.018606</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.018606</ArticleId><ArticleId IdType="pubmed">25740331</ArticleId><ArticleId IdType="pmc">4348560</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Kim S, Pant B (1992) Amyotrophic Lateral Sclerosis (ALS): A Phylogenetic disease of the corticomotoneuron? Muscle Nerve 15(2):219&#x2013;224. https://doi.org/10.1002/mus.880150215</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880150215</ArticleId><ArticleId IdType="pubmed">1549143</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Pant B, Stewart H (1993) Cortical excitability in amyotrophic lateral sclerosis: a clue to pathogenesis. Can J Neurol Sci 20(1):11&#x2013;16. https://doi.org/10.1017/s031716710004734x</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/s031716710004734x</ArticleId><ArticleId IdType="pubmed">8096792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills KR, Nithi KA (1997) Corticomotor threshold is reduced in early sporadic amyotrophic lateral sclerosis. Muscle Nerve 20(9):1137&#x2013;1141. https://doi.org/10.1002/(sici)1097-4598(199709)20:9&lt;3c1137::aid-mus7&gt;3e3.0.co;2-9</Citation></Reference><Reference><Citation>Eisen A, Nakajima M, Weber M (1998) Corticomotorneuronal hyper-excitability in amyotrophic lateral sclerosis. J Neurol Sci 160(Suppl 1):S64-68. https://doi.org/10.1016/s0022-510x(98)00200-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(98)00200-7</ArticleId><ArticleId IdType="pubmed">9851652</ArticleId></ArticleIdList></Reference><Reference><Citation>Weber M, Eisen A, Nakajima M (2000) Corticomotoneuronal activity in ALS: changes in the peristimulus time histogram over time. Clin Neurophysiol 111(1):169&#x2013;177. https://doi.org/10.1016/s1388-2457(99)00190-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1388-2457(99)00190-x</ArticleId><ArticleId IdType="pubmed">10656525</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanette G, Tamburin S, Manganotti P, Refatti N, Forgione A, Rizzuto N (2002) Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 113(11):1688&#x2013;1697. https://doi.org/10.1016/s1388-2457(02)00288-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1388-2457(02)00288-2</ArticleId><ArticleId IdType="pubmed">12417221</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, Nicholson GA, Ng K, Howells J, Kril JJ, Yiannikas C, Kiernan MC et al (2015) Cortical function in asymptomatic carriers and patients with C9orf72 amyotrophic lateral sclerosis. JAMA Neurol 72(11):1268&#x2013;1274. https://doi.org/10.1001/jamaneurol.2015.1872</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1872</ArticleId><ArticleId IdType="pubmed">26348842</ArticleId><ArticleId IdType="pmc">4707047</ArticleId></ArticleIdList></Reference><Reference><Citation>Van den Bos MAJ, Higashihara M, Geevasinga N, Menon P, Kiernan MC, Vucic S (2018) Imbalance of cortical facilitatory and inhibitory circuits underlies hyperexcitability in ALS. Neurology 91(18):e1669&#x2013;e1676. https://doi.org/10.1212/WNL.0000000000006438</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006438</ArticleId><ArticleId IdType="pubmed">30282772</ArticleId></ArticleIdList></Reference><Reference><Citation>Browne SE, Yang L, DiMauro JP, Fuller SW, Licata SC, Beal MF (2006) Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS. Neurobiol Dis 22(3):599&#x2013;610. https://doi.org/10.1016/j.nbd.2006.01.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.01.001</ArticleId><ArticleId IdType="pubmed">16616851</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Hughes EG, Shetty AS, Arlotta P, Goff LA, Bergles DE, Brown SP (2017) Changes in the excitability of neocortical neurons in a mouse model of amyotrophic lateral sclerosis are not specific to corticospinal neurons and are modulated by advancing disease. J Neurosci 37(37):9037&#x2013;9053. https://doi.org/10.1523/JNEUROSCI.0811-17.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0811-17.2017</ArticleId><ArticleId IdType="pubmed">28821643</ArticleId><ArticleId IdType="pmc">5597984</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Schonewille M, Siddique T, Schults ANA, Fu R, B&#xe4;r PR, Anelli R, Heckman CJ et al (2004) Hyperexcitability of cultured spinal motoneurons from presymptomatic ALS mice. J Neurophysiol 91(1):571&#x2013;575. https://doi.org/10.1152/jn.00665.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00665.2003</ArticleId><ArticleId IdType="pubmed">14523070</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo JJ, Siddique T, Fu R, Heckman CJ (2005) Increased persistent Na (+) current and its effect on excitability in motoneurones cultured from mutant SOD1 mice. J Physiol 563(Pt 3):843&#x2013;854. https://doi.org/10.1113/jphysiol.2004.074138</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2004.074138</ArticleId><ArticleId IdType="pubmed">15649979</ArticleId><ArticleId IdType="pmc">1665614</ArticleId></ArticleIdList></Reference><Reference><Citation>van Zundert B, Peuscher MH, Hynynen M, Chen A, Neve RL, Brown RH, Constantine-Paton M, Bellingham MC (2008) Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. J Neurosci 28(43):10864&#x2013;10874. https://doi.org/10.1523/JNEUROSCI.1340-08.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1340-08.2008</ArticleId><ArticleId IdType="pubmed">18945894</ArticleId><ArticleId IdType="pmc">3844745</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbasiouny SM, Amendola J, Durand J, Heckman CJ (2010) Evidence from computer simulations for alterations in the membrane biophysical properties and dendritic processing of synaptic inputs in mutant superoxide dismutase-1 motoneurons. J Neurosci 30(16):5544&#x2013;5558. https://doi.org/10.1523/JNEUROSCI.0434-10.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0434-10.2010</ArticleId><ArticleId IdType="pubmed">20410108</ArticleId><ArticleId IdType="pmc">4671367</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin E, Cazenave W, Cattaert D, Branchereau P (2013) Embryonic alteration of motoneuronal morphology induces hyperexcitability in the mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 54:116&#x2013;126. https://doi.org/10.1016/j.nbd.2013.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2013.02.011</ArticleId><ArticleId IdType="pubmed">23466698</ArticleId></ArticleIdList></Reference><Reference><Citation>Pambo-Pambo A, Durand J, Gueritaud JP (2009) Early excitability changes in lumbar motoneurons of transgenic SOD1G85R and SOD1G(93A-Low) mice. J Neurophysiol 102(6):3627&#x2013;3642. https://doi.org/10.1152/jn.00482.2009</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00482.2009</ArticleId><ArticleId IdType="pubmed">19828728</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan KA, Schuster JE, Fu R, Siddique T, Heckman CJ (2011) Altered postnatal maturation of electrical properties in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. J Physiol 589(Pt 9):2245&#x2013;2260. https://doi.org/10.1113/jphysiol.2010.200659</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2010.200659</ArticleId><ArticleId IdType="pubmed">21486770</ArticleId><ArticleId IdType="pmc">3098701</ArticleId></ArticleIdList></Reference><Reference><Citation>Bories C, Amendola J, Lamotte d&#x2019;Incamps B, Durand J (2007) Early electrophysiological abnormalities in lumbar motoneurons in a transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 25(2):451&#x2013;459. https://doi.org/10.1111/j.1460-9568.2007.05306.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2007.05306.x</ArticleId><ArticleId IdType="pubmed">17284186</ArticleId></ArticleIdList></Reference><Reference><Citation>Delestr&#xe9;e N, Manuel M, Iglesias C, Elbasiouny SM, Heckman CJ, Zytnicki D (2014) Adult spinal motoneurones are not hyperexcitable in a mouse model of inherited amyotrophic lateral sclerosis. J Physiol 592(7):1687&#x2013;1703. https://doi.org/10.1113/jphysiol.2013.265843</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2013.265843</ArticleId><ArticleId IdType="pubmed">24445319</ArticleId><ArticleId IdType="pmc">3979619</ArticleId></ArticleIdList></Reference><Reference><Citation>de Mart&#xed;nez-Silva ML, Imhoff-Manuel RD, Sharma A, Heckman CJ, Shneider NA, Roselli F, Zytnicki D, Manuel M (2018) Hypoexcitability precedes denervation in the large fast-contracting motor units in two unrelated mouse models of ALS. Elife 7:e30955. https://doi.org/10.7554/eLife.30955</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.30955</ArticleId><ArticleId IdType="pubmed">29580378</ArticleId><ArticleId IdType="pmc">5922970</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuo SW, Binder MD, Heckman CJ (2020) Excessive homeostatic gain in spinal motoneurons in a mouse model of amyotrophic lateral sclerosis. Sci Rep 10(1):9049. https://doi.org/10.1038/s41598-020-65685-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-65685-8</ArticleId><ArticleId IdType="pubmed">32493926</ArticleId><ArticleId IdType="pmc">7271238</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunet A, Stuart-Lopez G, Burg T, Scekic-Zahirovic J, Rouaux C (2020) Cortical circuit dysfunction as a potential driver of amyotrophic lateral sclerosis. Front Neurosci 14:363. https://doi.org/10.3389/fnins.2020.00363</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2020.00363</ArticleId><ArticleId IdType="pubmed">32410944</ArticleId><ArticleId IdType="pmc">7201269</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A (2021) The dying forward hypothesis of ALS: tracing its history. Brain Sci 11(3):300. https://doi.org/10.3390/brainsci11030300</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030300</ArticleId><ArticleId IdType="pubmed">33673524</ArticleId><ArticleId IdType="pmc">7997258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D (2011) The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J Mol Neurosci 43(3):470&#x2013;477. https://doi.org/10.1007/s12031-010-9467-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney EB, de Winter F, Verhaagen J (2014) ALS as a distal axonopathy: molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease. Front Neurosci 8:252. https://doi.org/10.3389/fnins.2014.00252</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2014.00252</ArticleId><ArticleId IdType="pubmed">25177267</ArticleId><ArticleId IdType="pmc">4132373</ArticleId></ArticleIdList></Reference><Reference><Citation>Court FA, Gillingwater TH, Melrose S, Sherman DL, Greenshields KN, Morton AJ, Harris JB, Willison HJ et al (2008) Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci 121(Pt 23):3901&#x2013;3911. https://doi.org/10.1242/jcs.031047</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.031047</ArticleId><ArticleId IdType="pubmed">19001504</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiura Y, Lin W (2011) Neuron-glia interactions: the roles of schwann cells in neuromuscular synapse formation and function. Biosci Rep 31(5):295&#x2013;302. https://doi.org/10.1042/BSR20100107</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20100107</ArticleId><ArticleId IdType="pubmed">21517783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML et al (2008) Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135(2):334&#x2013;342. https://doi.org/10.1016/j.cell.2008.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.10.002</ArticleId><ArticleId IdType="pubmed">18848351</ArticleId><ArticleId IdType="pmc">2933840</ArticleId></ArticleIdList></Reference><Reference><Citation>Inoue A, Setoguchi K, Matsubara Y, Okada K, Sato N, Iwakura Y, Higuchi O, Yamanashi Y (2009) Dok-7 activates the muscle receptor kinase MuSK and shapes synapse formation. Sci Signal 2(59):ra7. https://doi.org/10.1126/scisignal.2000113</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.2000113</ArticleId><ArticleId IdType="pubmed">19244212</ArticleId></ArticleIdList></Reference><Reference><Citation>Hippenmeyer S, Huber RM, Ladle DR, Murphy K, Arber S (2007) ETS transcription factor Erm controls subsynaptic gene expression in skeletal muscles. Neuron 55(5):726&#x2013;740. https://doi.org/10.1016/j.neuron.2007.07.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2007.07.028</ArticleId><ArticleId IdType="pubmed">17785180</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y, Rudell J, Ferns M (2009) Rapsyn interacts with the muscle acetylcholine receptor via alpha-helical domains in the alpha beta and epsilon subunit intracellular Loops. Neuroscience 163(1):222&#x2013;232. https://doi.org/10.1016/j.neuroscience.2009.05.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2009.05.057</ArticleId><ArticleId IdType="pubmed">19482062</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Xiong WC, Mei L (2018) Neuromuscular junction formation aging and disorders. Annu Rev Physiol 80:159&#x2013;188. https://doi.org/10.1146/annurev-physiol-022516-034255</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-physiol-022516-034255</ArticleId><ArticleId IdType="pubmed">29195055</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanes JR (2003) The basement membrane/basal lamina of skeletal muscle. J Biol Chem 278(15):12601&#x2013;12604. https://doi.org/10.1074/jbc.R200027200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R200027200</ArticleId><ArticleId IdType="pubmed">12556454</ArticleId></ArticleIdList></Reference><Reference><Citation>Patton BL (2003) Basal lamina and the organization of neuromuscular synapses. J Neurocytol 32(5&#x2013;8):883&#x2013;903. https://doi.org/10.1023/B:NEUR.0000020630.74955.19</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/B:NEUR.0000020630.74955.19</ArticleId><ArticleId IdType="pubmed">15034274</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimune H, Sanes JR, Carlson SS (2004) A synaptic laminin-calcium channel interaction organizes active zones in motor nerve terminals. Nature 432(7017):580&#x2013;587. https://doi.org/10.1038/nature03112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03112</ArticleId><ArticleId IdType="pubmed">15577901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Schenning MP, Lavidis NA, Noakes PG (2015) Loss of &#x3b2;2-laminin alters calcium sensitivity and voltage-gated calcium channel maturation of neurotransmission at the neuromuscular junction. J Physiol 593(1):245&#x2013;265. https://doi.org/10.1113/jphysiol.2014.284133</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2014.284133</ArticleId><ArticleId IdType="pubmed">25556799</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimune H, Valdez G, Jarad G, Moulson CL, M&#xfc;ller U, Miner JH, Sanes JR (2008) Laminins promote postsynaptic maturation by an autocrine mechanism at the neuromuscular junction. J Cell Biol 182(6):1201&#x2013;1215. https://doi.org/10.1083/jcb.200805095</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200805095</ArticleId><ArticleId IdType="pubmed">18794334</ArticleId><ArticleId IdType="pmc">2542479</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Lavidis NA, Noakes PG (2017) Loss of laminin-&#x3b1;4 results in pre- and postsynaptic modifications at the neuromuscular junction. FASEB J 31(4):1323&#x2013;1336. https://doi.org/10.1096/fj.201600899R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600899R</ArticleId><ArticleId IdType="pubmed">27998908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chou SM, Norris FH (1993) Amyotrophic lateral sclerosis: lower motor neuron disease spreading to upper motor neurons. Muscle Nerve 16(8):864&#x2013;869. https://doi.org/10.1002/mus.880160810</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880160810</ArticleId><ArticleId IdType="pubmed">8332139</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennel PF, Finiels F, Revah F, Mallet J (1996) Neuromuscular function impairment is not caused by motor neuron loss in FALS Mice: An Electromyographic Study. NeuroReport 7(8):1427&#x2013;1431. https://doi.org/10.1097/00001756-199605310-00021</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199605310-00021</ArticleId><ArticleId IdType="pubmed">8856691</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould TW, Buss RR, Vinsant S, Prevette D, Sun W, Knudson CM, Milligan CE, Oppenheim RW (2006) Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS. J Neurosci 26(34):8774&#x2013;8786. https://doi.org/10.1523/JNEUROSCI.2315-06.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2315-06.2006</ArticleId><ArticleId IdType="pubmed">16928866</ArticleId><ArticleId IdType="pmc">6674380</ArticleId></ArticleIdList></Reference><Reference><Citation>Dewil M, Dela Cruz VF, Van Den Bosch L, Robberecht W (2007) Inhibition of P38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death. Neurobiol Dis 26(2):332&#x2013;341. https://doi.org/10.1016/j.nbd.2006.12.023</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2006.12.023</ArticleId><ArticleId IdType="pubmed">17346981</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Schneider C, Xu L, Borg J, Spooren W, Caroni P (2000) Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J Neurosci 20(7):2534&#x2013;2542. https://doi.org/10.1523/JNEUROSCI.20-07-02534.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId><ArticleId IdType="pmc">6772256</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, Culver DG, Tennant P, Davis AA, Wang M, Castellano-Sanchez A, Khan J, Polak MA et al (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185(2):232&#x2013;240. https://doi.org/10.1016/j.expneurol.2003.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC (2016) Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Chem Neuroanat 76(Pt A):35&#x2013;47. https://doi.org/10.1016/j.jchemneu.2016.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchemneu.2016.03.003</ArticleId><ArticleId IdType="pubmed">27038603</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A, Lyashchenko AK, Lu L, Nasrabady SE, Elmaleh M, Mendelsohn M, Nemes A, Tapia JC et al (2016) ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat Commun 7:10465. https://doi.org/10.1038/ncomms10465</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms10465</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId><ArticleId IdType="pmc">4742863</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G, Demestre M, Zuko A, Been M, Higelin J, Dieterl&#xe9; S, Goy MA, Mallik M et al (2019) FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat Neurosci 22(11):1793&#x2013;1805. https://doi.org/10.1038/s41593-019-0498-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0498-9</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId><ArticleId IdType="pmc">6858880</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker AK, Spiller KJ, Ge G, Zheng A, Xu Y, Zhou M, Tripathy K, Kwong LK (2015) Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43. Acta Neuropathol 130(5):643&#x2013;660. https://doi.org/10.1007/s00401-015-1460-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1460-x</ArticleId><ArticleId IdType="pubmed">26197969</ArticleId><ArticleId IdType="pmc">5127391</ArticleId></ArticleIdList></Reference><Reference><Citation>Riemslagh FW, van der Toorn EC, Verhagen RFM, Maas A, Bosman LWJ, Hukema RK, Willemsen R (2021) Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice. Dis Model Mech dmm 044842. https://doi.org/10.1242/dmm.044842 .</Citation></Reference><Reference><Citation>Shahidullah M, Le Marchand SJ, Fei H, Zhang J, Pandey UB, Dalva MB, Pasinelli P, Levitan IB (2013) Defects in synapse structure and function precede motor neuron degeneration in drosophila models of FUS-related ALS. J Neurosci 33(50):19590&#x2013;19598. https://doi.org/10.1523/JNEUROSCI.3396-13.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3396-13.2013</ArticleId><ArticleId IdType="pubmed">24336723</ArticleId><ArticleId IdType="pmc">3858628</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakowski SA, Lunn JS, Busta AS, Oh SS, Zamora-Berridi G, Palmer M, Rosenberg AA, Philip SG (2012) Neuromuscular effects of G93A-SOD1 expression in zebrafish. Mol Neurodegener 7:44. https://doi.org/10.1186/1750-1326-7-44</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-44</ArticleId><ArticleId IdType="pubmed">22938571</ArticleId><ArticleId IdType="pmc">3506515</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh T, Lyon AN, Pineda RH, Wang C, Janssen PML, Canan BD, Burghes AHM, Beattie CE (2010) A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis Model Mech 3(9&#x2013;10):652&#x2013;662. https://doi.org/10.1242/dmm.005538</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dmm.005538</ArticleId><ArticleId IdType="pubmed">20504969</ArticleId><ArticleId IdType="pmc">2931540</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P (2006) Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat Neurosci 9(3):408&#x2013;419. https://doi.org/10.1038/nn1653</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Gordon T (2007) Time course of preferential motor unit loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis. Neurobiol Dis 28(2):154&#x2013;164. https://doi.org/10.1016/j.nbd.2007.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2007.07.003</ArticleId><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E, Martineau &#xc9;, Robitaille R (2017) Opposite synaptic alterations at the neuromuscular junction in an ALS mouse model: when motor units matter. J Neurosci 37(37):8901&#x2013;8918. https://doi.org/10.1523/JNEUROSCI.3090-16.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3090-16.2017</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId><ArticleId IdType="pmc">6596800</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer AM, Sanes JR, Lichtman JWA (2005) Compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J Comp Neurol 490(3):209&#x2013;219. https://doi.org/10.1002/cne.20620</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.20620</ArticleId><ArticleId IdType="pubmed">16082680</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J, Putman CT, Tyreman N, Gordon T (2008) Preferential motor unit loss in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. J Physiol 586(14):3337&#x2013;3351. https://doi.org/10.1113/jphysiol.2007.149286</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2007.149286</ArticleId><ArticleId IdType="pubmed">18467368</ArticleId><ArticleId IdType="pmc">2538809</ArticleId></ArticleIdList></Reference><Reference><Citation>Martineau &#xc9;, Di Polo A, Vande Velde C, Robitaille R 2018 Dynamic neuromuscular remodeling precedes motor-unit loss in a mouse model of ALS Elife 7 https://doi.org/10.7554/eLife.41973</Citation></Reference><Reference><Citation>Maselli RA, Wollman RL, Leung C, Distad B, Palombi S, Richman DP, Salazar-Grueso EF, Roos RP (1993) Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve 16(11):1193&#x2013;1203. https://doi.org/10.1002/mus.880161109</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880161109</ArticleId><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G, Bauch&#xe9; S, Gonzalez de Aguilar JL, Brochier G, Mandjee N, Tanguy ML, Hussain G, Behin A et al (2015) Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 2(4):362&#x2013;372. https://doi.org/10.1002/acn3.179</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.179</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId><ArticleId IdType="pmc">4402082</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S, Mansfield C, Jimenez-Moreno R, Del Gaizo MV, Yoshikawa M, Hampton TG, Prevette D, Caress J (2013) Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part II Results and Discussion. Brain Behav 3(4):431&#x2013;457. https://doi.org/10.1002/brb3.142</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.142</ArticleId><ArticleId IdType="pubmed">24381813</ArticleId><ArticleId IdType="pmc">3869683</ArticleId></ArticleIdList></Reference><Reference><Citation>Dirren E, Aebischer J, Rochat C, Towne C, Schneider BL, Aebischer P (2015) SOD1 Silencing in motoneurons or glia rescues neuromuscular function in ALS mice. Ann Clin Transl Neurol 2:167&#x2013;184. https://doi.org/10.1002/acn3.162</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.162</ArticleId><ArticleId IdType="pubmed">25750921</ArticleId><ArticleId IdType="pmc">4338957</ArticleId></ArticleIdList></Reference><Reference><Citation>McGown A, McDearmid JR, Panagiotaki N, Tong H, Al Mashhadi S, Redhead N, Lyon AN, Beattie CE et al (2013) Early interneuron dysfunction in ALS: insights from a mutant Sod1 zebrafish model. Ann Neurol 73(2):246&#x2013;258. https://doi.org/10.1002/ana.23780</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.23780</ArticleId><ArticleId IdType="pubmed">23281025</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh TM, Shaw PJ, McDearmid J (2014) A zebrafish model exemplifies the long preclinical period of motor neuron disease. J Neurol Neurosurg Psychiatry 85(11):1288&#x2013;1289. https://doi.org/10.1136/jnnp-2014-308288</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-308288</ArticleId><ArticleId IdType="pubmed">24970908</ArticleId></ArticleIdList></Reference><Reference><Citation>Mejia Maza A, Jarvis S, Lee WC, Cunningham TJ, Schiavo G, Secrier M, Fratta P, Sleigh JN et al (2021) NMJ-analyser identifies subtle early changes in mouse models of neuromuscular disease. Sci Rep 11(1):12251. https://doi.org/10.1038/s41598-021-91094-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-91094-6</ArticleId><ArticleId IdType="pubmed">34112844</ArticleId><ArticleId IdType="pmc">8192785</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia R, Liu Y, Yang L, Gal J, Zhu H, Jia J (2012) Motor neuron apoptosis and neuromuscular junction perturbation are prominent features in a drosophila model of Fus-mediated ALS. Mol Neurodegener 7:10. https://doi.org/10.1186/1750-1326-7-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-7-10</ArticleId><ArticleId IdType="pubmed">22443542</ArticleId><ArticleId IdType="pmc">3325858</ArticleId></ArticleIdList></Reference><Reference><Citation>Yerbury JJ, Farrawell NE, McAlary L (2020) Proteome homeostasis dysfunction: a unifying principle in ALS pathogenesis. Trends Neurosci 43(5):274&#x2013;284. https://doi.org/10.1016/j.tins.2020.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2020.03.002</ArticleId><ArticleId IdType="pubmed">32353332</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD (2001) Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues. Neurobiol Dis 8(6):933&#x2013;941. https://doi.org/10.1006/nbdi.2001.0443</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nbdi.2001.0443</ArticleId><ArticleId IdType="pubmed">11741389</ArticleId></ArticleIdList></Reference><Reference><Citation>Jonsson PA, Ernhill K, Andersen PM, Bergemalm D, Br&#xe4;nnstr&#xf6;m T, Gredal O, Nilsson P, Marklund SL (2004) Minute quantities of misfolded mutant superoxide dismutase-1 cause amyotrophic lateral sclerosis. Brain 127(Pt1):73&#x2013;88. https://doi.org/10.1093/brain/awh005</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awh005</ArticleId><ArticleId IdType="pubmed">14534160</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheroni C, Marino M, Tortarolo M, Veglianese P, De Biasi S, Fontana E, Zuccarello LV, Maynard C (2009) Functional alterations of the ubiquitin-proteasome system in motor neurons of a mouse model of familial amyotrophic lateral sclerosis. Hum Mol Genet 18(1):82&#x2013;96. https://doi.org/10.1093/hmg/ddn319</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn319</ArticleId><ArticleId IdType="pubmed">18826962</ArticleId></ArticleIdList></Reference><Reference><Citation>Devoy A, Kalmar B, Stewart M, Park H, Burke B, Noy SJ, Redhead Y, Humphrey J et al (2017) Humanized mutant FUS drives progressive motor neuron degeneration without aggregation in &#x201c;FUSDelta14&#x201d; Knockin Mice. Brain 140(11):2797&#x2013;2805. https://doi.org/10.1093/brain/awx248</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx248</ArticleId><ArticleId IdType="pubmed">29053787</ArticleId><ArticleId IdType="pmc">5841203</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Erauskin J, Tadokoro T, Baughn MW, Myers B, McAlonis-Downes M, Chillon-Marinas C, Asiaban JN, Artates J et al (2018) ALS/FTD-linked mutation in FUS suppresses intra-axonal protein synthesis and drives disease without nuclear loss-of-function of FUS. Neuron 100(4):816-830.e7. https://doi.org/10.1016/j.neuron.2018.09.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.09.044</ArticleId><ArticleId IdType="pubmed">30344044</ArticleId><ArticleId IdType="pmc">6277851</ArticleId></ArticleIdList></Reference><Reference><Citation>Fratta P, Sivakumar P, Humphrey J, Lo K, Ricketts T, Oliveira H, Brito-Armas JM, Kalmar B et al (2018) Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis. EMBO J 37(11):e98684. https://doi.org/10.15252/embj.201798684</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201798684</ArticleId><ArticleId IdType="pubmed">29764981</ArticleId><ArticleId IdType="pmc">5983119</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang YJ, Gendron TF, Ebbert MTW, O&#x2019;Raw AD, Yue M, Jansen-West K, Zhang X, Prudencio M et al (2018) Poly (GR) Impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat Med 24(8):1136&#x2013;1142. https://doi.org/10.1038/s41591-018-0071-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0071-1</ArticleId><ArticleId IdType="pubmed">29942091</ArticleId><ArticleId IdType="pmc">6520050</ArticleId></ArticleIdList></Reference><Reference><Citation>An D, Fujiki R, Iannitelli DE, Smerdon JW, Maity S, Rose MF, Gelber A, Wanaselja EK et al 2019 Stem cell-derived cranial and spinal motor neurons reveal proteostatic differences between ALS resistant and sensitive motor neurons Elife 8 https://doi.org/10.7554/eLife.44423</Citation></Reference><Reference><Citation>Maday S, Holzbaur ELF (2016) Compartment-specific regulation of autophagy in primary neurons. J Neurosci 36(22):5933&#x2013;5945. https://doi.org/10.1523/JNEUROSCI.4401-15.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4401-15.2016</ArticleId><ArticleId IdType="pubmed">27251616</ArticleId><ArticleId IdType="pmc">4887563</ArticleId></ArticleIdList></Reference><Reference><Citation>Sasaki S (2011) Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 70(5):349&#x2013;359. https://doi.org/10.1097/NEN.0b013e3182160690</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182160690</ArticleId><ArticleId IdType="pubmed">21487309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, Zheng JG, Shi Y et al (2011) SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 68(11):1440&#x2013;1446. https://doi.org/10.1001/archneurol.2011.250</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2011.250</ArticleId><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, Kinoshita Y, Kamada M et al (2010) Mutations of optineurin in amyotrophic lateral sclerosis. Nature 465(7295):223&#x2013;226. https://doi.org/10.1038/nature08971</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08971</ArticleId><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, Boycott KM, Gorrie GH, Siddique N, Yang Y, Fecto F et al (2011) Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477(7363):211&#x2013;215. https://doi.org/10.1038/nature10353</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId><ArticleId IdType="pmc">3169705</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, Couthouis J, Lu YF (2015) Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 347(6229):1436&#x2013;1441. https://doi.org/10.1126/science.aaa3650</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa3650</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId><ArticleId IdType="pmc">4437632</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers RS, Tungtur S, Tanaka T, Nadeau LL, Badawi Y, Wang H, Ni HM, Ding WX et al (2017) Impaired mitophagy plays a role in denervation of neuromuscular junctions in ALS mice. Front Neurosci 11:473. https://doi.org/10.3389/fnins.2017.00473</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00473</ArticleId><ArticleId IdType="pubmed">28890682</ArticleId><ArticleId IdType="pmc">5575151</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Huang B, Shi X, Gao L, Huang C (2018) Mutant UBQLN2P497H in Motor Neurons Leads to ALS-like Phenotypes and Defective Autophagy in Rats. Acta Neuropathol Commun 6(1):122. https://doi.org/10.1186/s40478-018-0627-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0627-9</ArticleId><ArticleId IdType="pubmed">30409191</ArticleId><ArticleId IdType="pmc">6225656</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick ND, Griffey CJ, Guarnieri P, Gerbino V, Wang X, Piersaint JA, Tapia JC, Rich MM et al (2017) Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc Natl Acad Sci U S A 114(39):E8294&#x2013;E8303. https://doi.org/10.1073/pnas.1704294114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId><ArticleId IdType="pmc">5625902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerbino V, Kaunga E, Ye J, Canzio D, O&#x2019;Keeffe S, Rudnick ND, Guarnieri P, Lutz CM et al (2020) The loss of TBK1 kinase activity in motor neurons or in all cell types differentially impacts ALS disease progression in SOD1 mice. Neuron 106(5):789-805.e5. https://doi.org/10.1016/j.neuron.2020.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.03.005</ArticleId><ArticleId IdType="pubmed">32220666</ArticleId></ArticleIdList></Reference><Reference><Citation>Sieverding K, Ulmer J, Bruno C, Satoh T, Tsao W, Freischmidt A, Akira S, Wong PC et al (2021) Hemizygous deletion of Tbk1 worsens neuromuscular junction pathology in TDP-43G298S transgenic mice. Exp Neurol 335:113496. https://doi.org/10.1016/j.expneurol.2020.113496</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113496</ArticleId><ArticleId IdType="pubmed">33038415</ArticleId></ArticleIdList></Reference><Reference><Citation>Chevalier-Larsen E, Holzbaur ELF (2006) Axonal transport and neurodegenerative disease. Biochim Biophys Acta 1762(11&#x2013;12):1094&#x2013;1108. https://doi.org/10.1016/j.bbadis.2006.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.04.002</ArticleId><ArticleId IdType="pubmed">16730956</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;nch C, Sedlmeier R, Meyer T, Homberg V, Sperfeld AD, Kurt A, Prudlo J, Peraus G et al (2004) Point mutations of the P150 subunit of dynactin (DCTN1) gene in ALS. Neurology 63(4):724&#x2013;726. https://doi.org/10.1212/01.wnl.0000134608.83927.b1</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000134608.83927.b1</ArticleId><ArticleId IdType="pubmed">15326253</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper-Knock J, Robins H, Niedermoser I, Wyles M, Heath PR, Higginbottom A, Walsh T, Kazoka M et al (2017) Targeted genetic screen in amyotrophic lateral sclerosis reveals novel genetic variants with synergistic effect on clinical phenotype. Front Mol Neurosci 10:370. https://doi.org/10.3389/fnmol.2017.00370</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00370</ArticleId><ArticleId IdType="pubmed">29170628</ArticleId><ArticleId IdType="pmc">5684183</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Yang L, Tang L, Chen L, Liu X, Fan D (2017) DCTN1 gene analysis in Chinese patients with sporadic amyotrophic lateral sclerosis. PLoS ONE 12(8):e0182572. https://doi.org/10.1371/journal.pone.0182572</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0182572</ArticleId><ArticleId IdType="pubmed">28792508</ArticleId><ArticleId IdType="pmc">5549744</ArticleId></ArticleIdList></Reference><Reference><Citation>Laird FM, Farah MH, Ackerley S, Hoke A, Maragakis N, Rothstein JD, Griffin J, Price DL et al (2008) Motor neuron disease occurring in a mutant dynactin mouse model is characterized by defects in vesicular trafficking. J Neurosci 28(9):1997&#x2013;2005. https://doi.org/10.1523/JNEUROSCI.4231-07.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4231-07.2008</ArticleId><ArticleId IdType="pubmed">18305234</ArticleId><ArticleId IdType="pmc">6671836</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka F, Niwa JI, Ishigaki S, Katsuno M, Waza M, Yamamoto M, Doyu M, Sobue G (2006) Gene expression profiling toward understanding of ALS pathogenesis. Ann N Y Acad Sci 1086:1&#x2013;10. https://doi.org/10.1196/annals.1377.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1377.011</ArticleId><ArticleId IdType="pubmed">17185501</ArticleId></ArticleIdList></Reference><Reference><Citation>Ku&#x17a;ma-Kozakiewicz M, Chudy A, Ka&#x17a;mierczak B, Dziewulska D, Usarek E, Bara&#x144;czyk-Ku&#x17a;ma A (2013) Dynactin deficiency in the CNS of humans with sporadic ALS and mice with genetically determined motor neuron degeneration. Neurochem Res. https://doi.org/10.1007/s11064-013-1160-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11064-013-1160-7</ArticleId><ArticleId IdType="pubmed">24078265</ArticleId><ArticleId IdType="pmc">3898179</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikenaka K, Kawai K, Katsuno M, Huang Z, Jiang YM, Iguchi Y, Kobayashi K, Kimata T et al (2013) Dnc-1/Dynactin 1 knockdown disrupts transport of autophagosomes and induces motor neuron degeneration. PLoS ONE 8(2):e54511. https://doi.org/10.1371/journal.pone.0054511</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0054511</ArticleId><ArticleId IdType="pubmed">23408943</ArticleId><ArticleId IdType="pmc">3567092</ArticleId></ArticleIdList></Reference><Reference><Citation>Bercier V, Hubbard JM, Fidelin K, Duroure K, Auer TO, Revenu C, Wyart C, Del Bene F (2019) Dynactin1 depletion leads to neuromuscular synapse instability and functional abnormalities. Mol Neurodegener 14(1):27. https://doi.org/10.1186/s13024-019-0327-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-019-0327-3</ArticleId><ArticleId IdType="pubmed">31291987</ArticleId><ArticleId IdType="pmc">6617949</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson TL, Cleveland DW (1999) Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons. Nat Neurosci 2(1):50&#x2013;56. https://doi.org/10.1038/4553</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4553</ArticleId><ArticleId IdType="pubmed">10195180</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, Suchowersky O, Julien JP, Figlewicz D (1996) SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 39(1):128&#x2013;131. https://doi.org/10.1002/ana.410390119</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410390119</ArticleId><ArticleId IdType="pubmed">8572658</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkhouse WS, Cunningham L, McFee I, Miller JML, Whitney D, Pelech SL, Krieger C (2008) Neuromuscular dysfunction in the mutant superoxide dismutase mouse model of amyotrophic lateral sclerosis. Amyotroph Lateral Scler 9(1):24&#x2013;34. https://doi.org/10.1080/17482960701725646</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701725646</ArticleId><ArticleId IdType="pubmed">18273716</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilsland LG, Sahai E, Kelly G, Golding M, Greensmith L, Schiavo G (2010) Deficits in axonal transport precede ALS symptoms in vivo. Proc Natl Acad Sci USA 107(47):20523&#x2013;20528. https://doi.org/10.1073/pnas.1006869107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1006869107</ArticleId><ArticleId IdType="pubmed">21059924</ArticleId><ArticleId IdType="pmc">2996651</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Du Z, Cao J, Petersen A, Liu H, Blackbourn LW, Huang CL et al (2014) Modeling ALS with IPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons. Cell Stem Cell 14(6):796&#x2013;809. https://doi.org/10.1016/j.stem.2014.02.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.02.004</ArticleId><ArticleId IdType="pubmed">24704493</ArticleId><ArticleId IdType="pmc">4230530</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P, Davies CH, Greensmith L et al (2018) Inhibiting P38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis 9(6):596. https://doi.org/10.1038/s41419-018-0624-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0624-8</ArticleId><ArticleId IdType="pubmed">29789529</ArticleId><ArticleId IdType="pmc">5964181</ArticleId></ArticleIdList></Reference><Reference><Citation>Morfini GA, Bosco DA, Brown H, Gatto R, Kaminska A, Song Y, Molla L, Baker L et al (2013) Inhibition of fast axonal transport by pathogenic SOD1 involves activation of P38 MAP kinase. PLoS One 8(6):e65235. https://doi.org/10.1371/journal.pone.0065235</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065235</ArticleId><ArticleId IdType="pubmed">23776455</ArticleId><ArticleId IdType="pmc">3680447</ArticleId></ArticleIdList></Reference><Reference><Citation>Alami NH, Smith RB, Carrasco MA, Williams LA, Winborn CS, Han SSW, Kiskinis E, Winborn B et al (2014) Axonal transport of TDP-43 MRNA granules is impaired by ALS-causing mutations. Neuron 81(3):536&#x2013;543. https://doi.org/10.1016/j.neuron.2013.12.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.12.018</ArticleId><ArticleId IdType="pubmed">24507191</ArticleId><ArticleId IdType="pmc">3939050</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, Dominov JA, Kenna BJ et al (2018) Genome-wide analyses identify KIF5A as a novel ALS gene. Neuron 97(6):1268-1283.e6. https://doi.org/10.1016/j.neuron.2018.02.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.02.027</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId><ArticleId IdType="pmc">5867896</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenner D, Yilmaz R, M&#xfc;ller K, Grehl T, Petri S, Meyer T, Grosskreutz J, Weydt P et al (2018) German ALS network MND-NET. Hot-spot KIF5A mutations cause familial ALS. Brain 141(3):688&#x2013;697. https://doi.org/10.1093/brain/awx370</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx370</ArticleId><ArticleId IdType="pubmed">29342275</ArticleId><ArticleId IdType="pmc">5837483</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandon EP, Lin W, D&#x2019;Amour KA, Pizzo DP, Dominguez B, Sugiura Y, Thode S, Ko CP (2003) Aberrant patterning of neuromuscular synapses in choline acetyltransferase-deficient mice. J Neurosci 23(2):539&#x2013;549. https://doi.org/10.1523/JNEUROSCI.23-02-00539.2003</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.23-02-00539.2003</ArticleId><ArticleId IdType="pubmed">12533614</ArticleId><ArticleId IdType="pmc">6741871</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato T (1989) Choline acetyltransferase activities in single spinal motor neurons from patients with amyotrophic lateral sclerosis. J Neurochem 52(2):636&#x2013;640. https://doi.org/10.1111/j.1471-4159.1989.tb09167.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.1989.tb09167.x</ArticleId><ArticleId IdType="pubmed">2911033</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda Y, Imai S, Nakanishi I, Ichikawa T, Deguchi T (1995) Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol Int 45(12):933&#x2013;939. https://doi.org/10.1111/j.1440-1827.1995.tb03418.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1827.1995.tb03418.x</ArticleId><ArticleId IdType="pubmed">8808298</ArticleId></ArticleIdList></Reference><Reference><Citation>Casas C, Herrando-Grabulosa M, Manzano R, Mancuso R, Osta R, Navarro X (2013) Early presymptomatic cholinergic dysfunction in a murine model of amyotrophic lateral sclerosis. Brain Behav 3(2):145&#x2013;158. https://doi.org/10.1002/brb3.104</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/brb3.104</ArticleId><ArticleId IdType="pubmed">23531559</ArticleId><ArticleId IdType="pmc">3607155</ArticleId></ArticleIdList></Reference><Reference><Citation>Tateno M, Kato S, Sakurai T, Nukina N, Takahashi R, Araki T (2009) Mutant SOD1 impairs axonal transport of choline acetyltransferase and acetylcholine release by sequestering KAP3. Hum Mol Genet 18(5):942&#x2013;955. https://doi.org/10.1093/hmg/ddn422</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn422</ArticleId><ArticleId IdType="pubmed">19088126</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagao M, Misawa H, Kato S, Hirai S (1998) Loss of cholinergic synapses on the spinal motor neurons of amyotrophic lateral sclerosis. J Neuropathol Exp Neurol 57(4):329&#x2013;333. https://doi.org/10.1097/00005072-199804000-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-199804000-00004</ArticleId><ArticleId IdType="pubmed">9600225</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugita S, Fleming LL, Wood C, Vaughan SK, Gomes MPSM, Camargo W, Naves LA, Prado VF et al (2016) VAChT overexpression increases acetylcholine at the synaptic cleft and accelerates aging of neuromuscular junctions. Skelet Muscle 6:31. https://doi.org/10.1186/s13395-016-0105-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13395-016-0105-7</ArticleId><ArticleId IdType="pubmed">27713817</ArticleId><ArticleId IdType="pmc">5050580</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand KK, Lee KM, Lee JD, Qiu H, Willis EF, Lavidis NA, Hilliard MA, Noakes PG (2018) Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis. FASEB J 32(5):2676&#x2013;2689. https://doi.org/10.1096/fj.201700835R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201700835R</ArticleId><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GAB, Drapeau P (2013) Calcium channel agonists protect against neuromuscular dysfunction in a genetic model of TDP-43 mutation in ALS. J Neurosci 33(4):1741&#x2013;1752. https://doi.org/10.1523/JNEUROSCI.4003-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4003-12.2013</ArticleId><ArticleId IdType="pubmed">23345247</ArticleId><ArticleId IdType="pmc">6618732</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong GAB, Drapeau P (2013) Loss and Gain of FUS Function impair neuromuscular synaptic transmission in a genetic model of ALS. Hum Mol Genet 22(21):4282&#x2013;4292. https://doi.org/10.1093/hmg/ddt278</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt278</ArticleId><ArticleId IdType="pubmed">23771027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose P, Armstrong GAB, Drapeau P (2019) Neuromuscular junction abnormalities in a zebrafish loss-of-function model of TDP-43. J Neurophysiol 121(1):285&#x2013;297. https://doi.org/10.1152/jn.00265.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/jn.00265.2018</ArticleId><ArticleId IdType="pubmed">30461368</ArticleId></ArticleIdList></Reference><Reference><Citation>Markert SM, Skoruppa M, Yu B, Mulcahy B, Zhen M, Gao S, Sendtner M, Stigloher C (2020) Overexpression of an ALS-associated FUS mutation in C. elegans disrupts NMJ morphology and leads to defective neuromuscular transmission. Biol Open 9(12):bio055129. https://doi.org/10.1242/bio.055129</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/bio.055129</ArticleId><ArticleId IdType="pubmed">33148607</ArticleId><ArticleId IdType="pmc">7746668</ArticleId></ArticleIdList></Reference><Reference><Citation>Machamer JB, Collins SE, Lloyd TE (2014) The ALS gene FUS regulates synaptic transmission at the drosophila neuromuscular junction. Hum Mol Genet 23(14):3810&#x2013;3822. https://doi.org/10.1093/hmg/ddu094</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu094</ArticleId><ArticleId IdType="pubmed">24569165</ArticleId><ArticleId IdType="pmc">4065154</ArticleId></ArticleIdList></Reference><Reference><Citation>Butti Z, Pan YE, Giacomotto J, Patten SA (2021) Reduced C9orf72 function leads to defective synaptic vesicle release and neuromuscular dysfunction in zebrafish. Commun Biol 4(1):792. https://doi.org/10.1038/s42003-021-02302-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-021-02302-y</ArticleId><ArticleId IdType="pubmed">34172817</ArticleId><ArticleId IdType="pmc">8233344</ArticleId></ArticleIdList></Reference><Reference><Citation>Vos M, Lauwers E, Verstreken P (2010) Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci 2:139. https://doi.org/10.3389/fnsyn.2010.00139</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsyn.2010.00139</ArticleId><ArticleId IdType="pubmed">21423525</ArticleId><ArticleId IdType="pmc">3059669</ArticleId></ArticleIdList></Reference><Reference><Citation>De Vos KJ, Chapman AL, Tennant ME, Manser C, Tudor EL, Lau KF, Brownlees J, Ackerley S (2007) Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal transport to reduce axonal mitochondria content. Hum Mol Genet 16(22):2720&#x2013;2728. https://doi.org/10.1093/hmg/ddm226</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddm226</ArticleId><ArticleId IdType="pubmed">17725983</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell NE, Lambert-Smith I, Mitchell K, McKenna J, McAlary L, Ciryam P, Vine KL, Saunders DN et al (2018) SOD1A4V aggregation alters ubiquitin homeostasis in a cell model of ALS. J Cell Sci 131(11). https://doi.org/10.1242/jcs.209122 .</Citation></Reference><Reference><Citation>Bendotti C, Calvaresi N, Chiveri L, Prelle A, Moggio M, Braga M, Silani V, De Biasi S (2001) Early Vacuolization and mitochondrial damage in motor neurons of FALS Mice are not associated with apoptosis or with changes in cytochrome oxidase histochemical reactivity. J Neurol Sci 191(1&#x2013;2):25&#x2013;33. https://doi.org/10.1016/s0022-510x(01)00627-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(01)00627-x</ArticleId><ArticleId IdType="pubmed">11676989</ArticleId></ArticleIdList></Reference><Reference><Citation>Magran&#xe9; J, Cortez C, Gan WB, Manfredi G (2014) Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet 23(6):1413&#x2013;1424. https://doi.org/10.1093/hmg/ddt528</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddt528</ArticleId><ArticleId IdType="pubmed">24154542</ArticleId></ArticleIdList></Reference><Reference><Citation>So E, Mitchell JC, Memmi C, Chennell G, Vizcay-Barrena G, Allison L, Shaw CE, Vance C (2018) Mitochondrial Abnormalities and Disruption of the Neuromuscular Junction precede the clinical phenotype and motor neuron loss in HFUSWT transgenic mice. Hum Mol Genet 27(3):463&#x2013;474. https://doi.org/10.1093/hmg/ddx415</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx415</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Moller A, Bauer CS, Cohen RN, Webster CP, De Vos KJ (2017) Amyotrophic lateral sclerosis-associated mutant SOD1 inhibits anterograde axonal transport of mitochondria by reducing Miro1 levels. Hum Mol Genet 26(23):4668&#x2013;4679. https://doi.org/10.1093/hmg/ddx348</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx348</ArticleId><ArticleId IdType="pubmed">28973175</ArticleId><ArticleId IdType="pmc">5886184</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf3;rotz GM, De Vos KJ, Vagnoni A, Ackerley S, Shaw CE, Miller CCJ (2012) Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria. Hum Mol Genet 21(9):1979&#x2013;1988. https://doi.org/10.1093/hmg/dds011</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds011</ArticleId><ArticleId IdType="pubmed">22258555</ArticleId><ArticleId IdType="pmc">3315205</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsujihata M, Hazama R, Yoshimura T, Satoh A, Mori M, Nagataki S (1984) The motor end-plate fine structure and ultrastructural localization of acetylcholine receptors in amyotrophic lateral sclerosis. Muscle Nerve 7(3):243&#x2013;249. https://doi.org/10.1002/mus.880070310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880070310</ArticleId><ArticleId IdType="pubmed">6708970</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshihara T, Ishii T, Iwata M, Nomoto M (1998) Ultrastructural and histochemical study of the motor end plates of the intrinsic laryngeal muscles in amyotrophic lateral sclerosis. Ultrastruct Pathol 22(2):121&#x2013;126. https://doi.org/10.3109/01913129809032266</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913129809032266</ArticleId><ArticleId IdType="pubmed">9615380</ArticleId></ArticleIdList></Reference><Reference><Citation>Narai H, Manabe Y, Nagai M, Nagano I, Ohta Y, Murakami T, Takehisa Y, Kamiya T et al (2009) Early detachment of neuromuscular junction proteins in ALS Mice with SODG93A mutation. Neurol Int 1(1):e16. https://doi.org/10.4081/ni.2009.e16</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2009.e16</ArticleId><ArticleId IdType="pubmed">21577353</ArticleId><ArticleId IdType="pmc">3093225</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma E, Inghilleri M, Conti L, Deflorio C, Frasca V, Manteca A, Pichiorri F, Roseti C et al (2011) Physiological characterization of human muscle acetylcholine receptors from ALS patients. Proc Natl Acad Sci U S A 108(50):20184&#x2013;20188. https://doi.org/10.1073/pnas.1117975108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1117975108</ArticleId><ArticleId IdType="pubmed">22128328</ArticleId><ArticleId IdType="pmc">3250127</ArticleId></ArticleIdList></Reference><Reference><Citation>Palma E, Reyes-Ruiz JM, Lopergolo D, Roseti C, Bertollini C, Ruffolo G, Cifelli P, Onesti E et al (2016) Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. Proc Natl Acad Sci U S A 113(11):3060&#x2013;3065. https://doi.org/10.1073/pnas.1600251113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1600251113</ArticleId><ArticleId IdType="pubmed">26929355</ArticleId><ArticleId IdType="pmc">4801305</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Martini M, Scicchitano BM, Romanello V, Boncompagni S, Nicoletti C, Pietrangelo L, De Panfilis S et al (2018) Muscle expression of SOD1G93A triggers the dismantlement of neuromuscular junction via PKC-Theta. Antioxid Redox Signal 28(12):1105&#x2013;1119. https://doi.org/10.1089/ars.2017.7054</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2017.7054</ArticleId><ArticleId IdType="pubmed">28931313</ArticleId></ArticleIdList></Reference><Reference><Citation>Campanari ML, Marian A, Ciura S, Kabashi E (2021) TDP-43 Regulation of AChE expression can mediate ALS-like phenotype in zebrafish. Cells 10(2):221. https://doi.org/10.3390/cells10020221</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10020221</ArticleId><ArticleId IdType="pubmed">33499374</ArticleId><ArticleId IdType="pmc">7911940</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellingham MC (2011) A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci Ther 17(1):4&#x2013;31. https://doi.org/10.1111/j.1755-5949.2009.00116.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1755-5949.2009.00116.x</ArticleId><ArticleId IdType="pubmed">20236142</ArticleId><ArticleId IdType="pmc">6493865</ArticleId></ArticleIdList></Reference><Reference><Citation>Deflorio C, Palma E, Conti L, Roseti C, Manteca A, Giacomelli E, Catalano M, Limatola C et al (2012) Riluzole blocks human muscle acetylcholine receptors. J Physiol 590(10):2519&#x2013;2528. https://doi.org/10.1113/jphysiol.2012.230201</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2012.230201</ArticleId><ArticleId IdType="pubmed">22431338</ArticleId><ArticleId IdType="pmc">3424768</ArticleId></ArticleIdList></Reference><Reference><Citation>Barik A, Lu Y, Sathyamurthy A, Bowman A, Shen C, Li L, Xiong W, Mei L (2014) LRP4 is critical for neuromuscular junction maintenance. J Neurosci 34(42):13892&#x2013;13905. https://doi.org/10.1523/JNEUROSCI.1733-14.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1733-14.2014</ArticleId><ArticleId IdType="pubmed">25319686</ArticleId><ArticleId IdType="pmc">4198535</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanmukha S, Narayanappa G, Nalini A, Alladi PA, Raju TR (2018) Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model. Dis Model Mech 11:(4). https://doi.org/10.1242/dmm.031997 .</Citation></Reference><Reference><Citation>P&#xe9;rez-Garc&#xed;a MJ, Burden SJ (2012) Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep 2(3):497&#x2013;502. https://doi.org/10.1016/j.celrep.2012.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2012.08.004</ArticleId><ArticleId IdType="pubmed">22939980</ArticleId><ArticleId IdType="pmc">3462266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantor S, Zhang W, Delestr&#xe9;e N, Rem&#xe9;dio L, Mentis GZ, Burden SJ 2018 Preserving neuromuscular synapses in ALS by stimulating MuSK with a therapeutic agonist antibody Elife 7 https://doi.org/10.7554/eLife.34375</Citation></Reference><Reference><Citation>Sengupta-Ghosh A, Dominguez SL, Xie L, Barck KH, Jiang Z, Earr T, Imperio J, Phu L et al (2019) Muscle specific kinase (MuSK) activation preserves neuromuscular junctions in the diaphragm but is not sufficient to provide a functional benefit in the SOD1G93A mouse model of ALS. Neurobiol Dis 124:340&#x2013;352. https://doi.org/10.1016/j.nbd.2018.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.12.002</ArticleId><ArticleId IdType="pubmed">30528255</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi T, Tezuka T, Fukudome T, Watanabe Y, Sagara H, Yamanashi Y (2020) Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: implications in robustness of neuromuscular transmission. Biochem Biophys Res Commun 523(1):214&#x2013;219. https://doi.org/10.1016/j.bbrc.2019.12.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2019.12.011</ArticleId><ArticleId IdType="pubmed">31848047</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimura S, Okada T, Tezuka T, Chiyo T, Kasahara Y, Yoshimura T, Motomura M, Yoshida N et al (2014) Neuromuscular disease. DOK7 gene therapy benefits mouse models of diseases characterized by defects in the neuromuscular junction. Science 345(6203):1505&#x2013;1508. https://doi.org/10.1126/science.1250744</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1250744</ArticleId><ArticleId IdType="pubmed">25237101</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyoshi S, Tezuka T, Arimura S, Tomono T, Okada T, Yamanashi Y (2017) DOK7 gene therapy enhances motor activity and life span in ALS model mice. EMBO Mol Med 9(7):880&#x2013;889. https://doi.org/10.15252/emmm.201607298</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201607298</ArticleId><ArticleId IdType="pubmed">28490573</ArticleId><ArticleId IdType="pmc">5494517</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler M, Manley HA, Purcell AL, Deshpande SS, Hamilton TA, Kan RK, Oyler G, Lockridge O et al (2004) Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice. Muscle Nerve 30(3):317&#x2013;327. https://doi.org/10.1002/mus.20099</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.20099</ArticleId><ArticleId IdType="pubmed">15318343</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasool CG, Bradley WG, Connolly B, Baruah JK (1983) Acetylcholinesterase and ATPases in motor neuron degenerative diseases. Muscle Nerve 6(6):430&#x2013;435. https://doi.org/10.1002/mus.880060606</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880060606</ArticleId><ArticleId IdType="pubmed">6137769</ArticleId></ArticleIdList></Reference><Reference><Citation>Festoff BW, Fernandez HL (1981) Plasma and red blood cell acetylcholinesterase in amyotrophic lateral sclerosis. Muscle Nerve 4(1):41&#x2013;47. https://doi.org/10.1002/mus.880040108</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880040108</ArticleId><ArticleId IdType="pubmed">7231444</ArticleId></ArticleIdList></Reference><Reference><Citation>Niebr&#xf3;j-Dobosz I, Domitrz I, Mickielewicz A (1999) Cytotoxic activity of serum and cerebrospinal fluid of amyotrophic lateral sclerosis (ALS) patients against acetylcholinesterase. Folia Neuropathol 37(2):107&#x2013;112</Citation><ArticleIdList><ArticleId IdType="pubmed">10464429</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez HL, Stiles JR, Donoso JA (1986) Skeletal muscle acetylcholinesterase molecular forms in amyotrophic lateral sclerosis. Muscle Nerve 9(5):399&#x2013;406. https://doi.org/10.1002/mus.880090504</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880090504</ArticleId><ArticleId IdType="pubmed">3724786</ArticleId></ArticleIdList></Reference><Reference><Citation>Aquilonius SM, Askmark H, Eckern&#xe4;s SA, Gillberg PG, Hilton-Brown P, Rydin E, St&#xe5;lberg E (1986) Cholinesterase inhibitors lack therapeutic effect in amyotrophic lateral sclerosis. A controlled study of physostigmine versus neostigmine. Acta Neurol Scand 73(6):628&#x2013;632. https://doi.org/10.1111/j.1600-0404.1986.tb04610.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1986.tb04610.x</ArticleId><ArticleId IdType="pubmed">3529799</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotkine M, Marc G, Rozenstein L, Leah R, Einstein O, Ofira E, Abramsky O, Oded A et al (2013) Presymptomatic treatment with acetylcholinesterase antisense oligonucleotides prolongs survival in ALS (G93A-SOD1) mice. Biomed Res Int 2013:845345. https://doi.org/10.1155/2013/845345</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/845345</ArticleId><ArticleId IdType="pubmed">24455732</ArticleId></ArticleIdList></Reference><Reference><Citation>Pramatarova A, Lagani&#xe8;re J, Roussel J, Brisebois K, Rouleau GA (2001) Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci 21(10):3369&#x2013;3374. https://doi.org/10.1523/JNEUROSCI.21-10-03369.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-10-03369.2001</ArticleId><ArticleId IdType="pubmed">11331366</ArticleId><ArticleId IdType="pmc">6762496</ArticleId></ArticleIdList></Reference><Reference><Citation>Lino MM, Schneider C, Caroni P (2002) Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease. J Neurosci 22(12):4825&#x2013;4832. https://doi.org/10.1523/JNEUROSCI.22-12-04825.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.22-12-04825.2002</ArticleId><ArticleId IdType="pubmed">12077179</ArticleId><ArticleId IdType="pmc">6757755</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Aucello M, Rizzuto E, Beccafico S, Mammucari C, Boncompagni S, Bonconpagni S, Belia S et al (2008) Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab 8(5):425&#x2013;436. https://doi.org/10.1016/j.cmet.2008.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ (2010) Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum Mol Genet 19(11):2284&#x2013;2302. https://doi.org/10.1093/hmg/ddq106</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId><ArticleId IdType="pmc">2865380</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin LJ, Wong M (2020) Skeletal muscle-restricted expression of human SOD1 in transgenic mice causes a fatal ALS-like syndrome. Front Neurol 11:592851. https://doi.org/10.3389/fneur.2020.592851</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.592851</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId><ArticleId IdType="pmc">7767933</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcuzzo S, Zucca I, Mastropietro A, de Rosbo NK, Cavalcante P, Tartari S, Bonanno S, Preite L et al (2011) Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study. Exp Neurol 231(1):30&#x2013;37. https://doi.org/10.1016/j.expneurol.2011.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2011.05.007</ArticleId><ArticleId IdType="pubmed">21620832</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Lepore E, Martini M, Barberi L, Nunn A, Scicchitano BM, Musar&#xf2; A (2018) Metabolic changes associated with muscle expression of SOD1G93A. Front Physiol 9:831. https://doi.org/10.3389/fphys.2018.00831</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00831</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId><ArticleId IdType="pmc">6048270</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner BJ, Lopes EC, Cheema SS (2003) Neuromuscular accumulation of mutant superoxide dismutase 1 aggregates in a transgenic mouse model of familial amyotrophic lateral sclerosis. Neurosci Lett 350(2):132&#x2013;136. https://doi.org/10.1016/s0304-3940(03)00893-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0304-3940(03)00893-0</ArticleId><ArticleId IdType="pubmed">12972170</ArticleId></ArticleIdList></Reference><Reference><Citation>Onesto E, Rusmini P, Crippa V, Ferri N, Zito A, Galbiati M, Poletti A (2011) Muscle cells and motoneurons differentially remove mutant SOD1 causing familial amyotrophic lateral sclerosis. J Neurochem 118(2):266&#x2013;280. https://doi.org/10.1111/j.1471-4159.2011.07298.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2011.07298.x</ArticleId><ArticleId IdType="pubmed">21554318</ArticleId><ArticleId IdType="pmc">3206220</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R, Bhattacharya A, Chintalaramulu N, Jernigan AL, Liu Y, Van Remmen H, Chaudhuri AR (2012) Protein misfolding mitochondrial dysfunction and muscle loss are not directly dependent on soluble and aggregation state of MSOD1 protein in skeletal muscle of ALS. Biochem Biophys Res Commun 417(4):1275&#x2013;1279. https://doi.org/10.1016/j.bbrc.2011.12.126</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2011.12.126</ArticleId><ArticleId IdType="pubmed">22234310</ArticleId></ArticleIdList></Reference><Reference><Citation>Crippa V, Galbiati M, Boncoraglio A, Rusmini P, Onesto E, Giorgetti E, Cristofani R, Zito A et al (2013) Motoneuronal and muscle-selective removal of ALS-related misfolded proteins. Biochem Soc Trans 41(6):1598&#x2013;1604. https://doi.org/10.1042/BST20130118</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20130118</ArticleId><ArticleId IdType="pubmed">24256261</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei R, Bhattacharya A, Hamilton RT, Jernigan AL, Chaudhuri AR (2013) Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network. Biochem Biophys Res Commun 438(1):218&#x2013;223. https://doi.org/10.1016/j.bbrc.2013.07.060</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2013.07.060</ArticleId><ArticleId IdType="pubmed">23886956</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, Calvo AC, Gasco S, Mu&#xf1;oz MJ, Zaragoza P, Osta R (2015) Time-point dependent activation of autophagy and the UPS in SOD1G93A mice skeletal muscle. PLoS One 10(8):e0134830. https://doi.org/10.1371/journal.pone.0134830</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0134830</ArticleId><ArticleId IdType="pubmed">26244336</ArticleId><ArticleId IdType="pmc">4526523</ArticleId></ArticleIdList></Reference><Reference><Citation>McCampbell A, Cole T, Wegener AJ, Tomassy GS, Setnicka A, Farley BJ, Schoch KM, Hoye ML et al (2018) Antisense oligonucleotides extend survival and reverse decrement in muscle response in ALS models. J Clin Invest 128(8):3558&#x2013;3567. https://doi.org/10.1172/JCI99081</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI99081</ArticleId><ArticleId IdType="pubmed">30010620</ArticleId><ArticleId IdType="pmc">6063493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorar&#xfa; G, Orsetti V, Buratti E, Baralle F, Cima V, Volpe M, D&#x2019;ascenzo C, Palmieri A et al (2010) TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11(1&#x2013;2):240&#x2013;243. https://doi.org/10.3109/17482960902810890</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902810890</ArticleId><ArticleId IdType="pubmed">19306141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cykowski MD, Powell SZ, Appel JW, Arumanayagam AS, Rivera AL, Appel SH (2018) Phosphorylated TDP-43 (PTDP-43) Aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis. Acta Neuropathol Commun 6(1):28. https://doi.org/10.1186/s40478-018-0528-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0528-y</ArticleId><ArticleId IdType="pubmed">29653597</ArticleId><ArticleId IdType="pmc">5899326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tada M, Kon T, Miki Y, Tanji K, Kurotaki H, Tomiyama M, Ishihara T et al (2019) Phosphorylated TDP-43 Aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions. Acta Neuropathol Commun 7(1):165. https://doi.org/10.1186/s40478-019-0824-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-019-0824-1</ArticleId><ArticleId IdType="pubmed">31661037</ArticleId><ArticleId IdType="pmc">6816170</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A, Zoll J, Ponsot E, N&#x2019;guessan B, Tranchant C, Loeffler JP, Lampert E, (2006) Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: a temporal study in man. Exp Neurol 198(1):25&#x2013;30. https://doi.org/10.1016/j.expneurol.2005.07.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2005.07.020</ArticleId><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyderman H, Chen T (2014) Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target? Br J Pharmacol 171(8):2191&#x2013;2205. https://doi.org/10.1111/bph.12476</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12476</ArticleId><ArticleId IdType="pubmed">24148000</ArticleId><ArticleId IdType="pmc">3976630</ArticleId></ArticleIdList></Reference><Reference><Citation>Vielhaber S, Winkler K, Kirches E, Kunz D, B&#xfc;chner M, Feistner H, Elger CE, Ludolph AC (1999) Visualization of defective mitochondrial function in skeletal muscle fibers of patients with sporadic amyotrophic lateral sclerosis. J Neurol Sci 169(1&#x2013;2):133&#x2013;139. https://doi.org/10.1016/s0022-510x(99)00236-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(99)00236-1</ArticleId><ArticleId IdType="pubmed">10540022</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung MJ, Suh YL (2002) Ultrastructural Changes of mitochondria in the skeletal muscle of patients with amyotrophic lateral sclerosis. Ultrastruct Pathol 26(1):3&#x2013;7. https://doi.org/10.1080/01913120252934260</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01913120252934260</ArticleId><ArticleId IdType="pubmed">12028652</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, di Scala F, Rene F, de Tapia M, Oudart H, Pradat PF, Meininger V, Loeffler JP (2003) Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis. FASEB J 17(14):2091&#x2013;2093. https://doi.org/10.1096/fj.02-1182fje</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.02-1182fje</ArticleId><ArticleId IdType="pubmed">14500553</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Oudart H, Ren&#xe9; F, Gonzalez de Aguilar JL, Loeffler JP (2004) Evidence for defective energy homeostasis in amyotrophic lateral sclerosis: benefit of a high-energy diet in a transgenic mouse model. Proc Natl Acad Sci U S A 101(30):11159&#x2013;11164. https://doi.org/10.1073/pnas.0402026101</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402026101</ArticleId><ArticleId IdType="pubmed">15263088</ArticleId><ArticleId IdType="pmc">503756</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch E, Semrad T, Belsito VS, FitzGibbons C, Reilly M, Hayakawa K, Suzuki M (2019) C9ORF72-related cellular pathology in skeletal myocytes derived from ALS-patient induced pluripotent stem cells. Dis Model Mech 12(8). https://doi.org/10.1242/dmm.039552 .</Citation></Reference><Reference><Citation>Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, Ferrier A, Couratier P (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256(8):1236&#x2013;1242. https://doi.org/10.1007/s00415-009-5100-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-009-5100-z</ArticleId><ArticleId IdType="pubmed">19306035</ArticleId></ArticleIdList></Reference><Reference><Citation>Funalot B, Desport JC, Sturtz F, Camu W, Couratier P (2009) High metabolic level in patients with familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler 10(2):113&#x2013;117. https://doi.org/10.1080/17482960802295192</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960802295192</ArticleId><ArticleId IdType="pubmed">18792852</ArticleId></ArticleIdList></Reference><Reference><Citation>Genin EC, Madji Hounoum B, Bannwarth S, Fragaki K, Lacas-Gervais S, Mauri-Crouzet A, Lespinasse F, Neveu J et al (2019) Mitochondrial defect in muscle precedes neuromuscular junction degeneration and motor neuron death in CHCHD10S59L/+ Mouse. Acta Neuropathol 138(1):123&#x2013;145. https://doi.org/10.1007/s00401-019-01988-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01988-z</ArticleId><ArticleId IdType="pubmed">30874923</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller FL, Song W, Jang YC, Liu Y, Sabia M, Richardson A, Van Remmen H (2007) Denervation-induced skeletal muscle atrophy is associated with increased mitochondrial ROS production. Am J Physiol Regul Integr Comp Physiol 293(3):R1159-1168. https://doi.org/10.1152/ajpregu.00767.2006</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpregu.00767.2006</ArticleId><ArticleId IdType="pubmed">17584954</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Y, Karam C, Yi J, Zhang L, Li X, Yoon D, Wang H, Dhakal K et al (2018) ROS-related mitochondrial dysfunction in skeletal muscle of an ALS mouse model during the disease progression. Pharmacol Res 138:25&#x2013;36. https://doi.org/10.1016/j.phrs.2018.09.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2018.09.008</ArticleId><ArticleId IdType="pubmed">30236524</ArticleId><ArticleId IdType="pmc">6263743</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L, Gonzalez de Aguilar JL, Echaniz-Laguna A, Eschbach J, Rene F, Oudart H, Halter B, Huze C et al (2009) Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS One 4(4):e5390. https://doi.org/10.1371/journal.pone.0005390</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0005390</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId><ArticleId IdType="pmc">2671839</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo G, Yi J, Ma C, Xiao Y, Yi F, Yu T, Zhou J (2013) Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS One 8(12):e82112. https://doi.org/10.1371/journal.pone.0082112</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0082112</ArticleId><ArticleId IdType="pubmed">24324755</ArticleId><ArticleId IdType="pmc">3855744</ArticleId></ArticleIdList></Reference><Reference><Citation>Da Cruz S, Parone PA, Lopes VS, Lillo C, McAlonis-Downes M, Lee SK, Vetto AP, Petrosyan S (2012) Elevated PGC-1&#x3b1; activity sustains mitochondrial biogenesis and muscle function without extending survival in a mouse model of inherited ALS. Cell Metab 5:778&#x2013;786. https://doi.org/10.1016/j.cmet.2012.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2012.03.019</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuyama Y, Mizuno T, Inoue H, Kimoto K (1997) Amyotrophic lateral sclerosis with anti-acetylcholine receptor antibody. Intern Med 36(4):312&#x2013;315. https://doi.org/10.2169/internalmedicine.36.312</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.36.312</ArticleId><ArticleId IdType="pubmed">9187574</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehanna R, Patton EL, Phan CL, Harati Y (2012) Amyotrophic lateral sclerosis with positive anti-acetylcholine receptor antibodies. Case report and review of the literature. J Clin Neuromuscul Dis 14(2):82&#x2013;85. https://doi.org/10.1097/CND.0b013e31824db163</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CND.0b013e31824db163</ArticleId><ArticleId IdType="pubmed">23172389</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivner MH, Liu S, Quarles B, Fleenor B, Shen C, Pan J, Mei L (2017) Agrin and low-density lipoprotein-related receptor protein 4 antibodies in amyotrophic lateral sclerosis patients. Muscle Nerve 55(3):430&#x2013;432. https://doi.org/10.1002/mus.25438</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.25438</ArticleId><ArticleId IdType="pubmed">27756107</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos JS, Zisimopoulou P, Rentzos M, Karandreas N, Zouvelou V, Evangelakou P, Tsonis A, Thomaidis T et al (2014) LRP4 antibodies in serum and CSF from amyotrophic lateral sclerosis patients. Ann Clin Transl Neurol 1(2):80&#x2013;87. https://doi.org/10.1002/acn3.26</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.26</ArticleId><ArticleId IdType="pubmed">25356387</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzartos J, Zisimopoulou P, Tsonis A, Evangelakou P, Rentzos M, Karandreas N, Zouvelou V, Thomaidis T et al (2015) LRP4 antibodies are frequent in serum and CSF from amyotrophic lateral sclerosis patients (S34.004). Neurology 84(14 Supplement). https://doi.org/10.1002/acn3.26 .</Citation></Reference><Reference><Citation>Lei L, Shen XM, Wang SY, Lu Y, Wang SB, Chen H, Liu Z, Ouyang YS et al (2019) Presence of antibodies against low-density lipoprotein receptor-related protein 4 and impairment of neuromuscular junction in a Chinese cohort of amyotrophic lateral sclerosis. Chin Med J (Engl) 132(12):1487&#x2013;1489. https://doi.org/10.1097/CM9.0000000000000284</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CM9.0000000000000284</ArticleId></ArticleIdList></Reference><Reference><Citation>Conradi S, Ronnevi LO (1994) Further studies on the occurrence of serum autoantibodies against a membrane bound AChE fraction in ALS/MND patients and controls. J Neurol Sci 124(Suppl):67&#x2013;69. https://doi.org/10.1016/0022-510x(94)90182-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510x(94)90182-1</ArticleId><ArticleId IdType="pubmed">7807147</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;ggstr&#xf6;m B, Andersen PM, Hjalmarsson K, Binzer M, Forsgren L (1997) Autoimmunity and ALS: studies on antibodies to acetylcholinesterase in sera. Acta Neurol Scand 95(2):111&#x2013;114. https://doi.org/10.1111/j.1600-0404.1997.tb00079.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1997.tb00079.x</ArticleId><ArticleId IdType="pubmed">9059731</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Z, Ko CP (2008) The role of glial cells in the formation and maintenance of the neuromuscular junction. Ann N Y Acad Sci 1132:19&#x2013;28. https://doi.org/10.1196/annals.1405.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1196/annals.1405.016</ArticleId><ArticleId IdType="pubmed">18567850</ArticleId></ArticleIdList></Reference><Reference><Citation>Barik A, Li L, Sathyamurthy A, Xiong WC, Mei L (2016) Schwann cells in neuromuscular junction formation and maintenance. J Neurosci 36(38):9770&#x2013;9781. https://doi.org/10.1523/JNEUROSCI.0174-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0174-16.2016</ArticleId><ArticleId IdType="pubmed">27656017</ArticleId><ArticleId IdType="pmc">5030347</ArticleId></ArticleIdList></Reference><Reference><Citation>Jahromi BS, Robitaille R, Charlton MP (1992) Transmitter release increases intracellular calcium in perisynaptic Schwann cells in situ. Neuron 8(6):1069&#x2013;1077. https://doi.org/10.1016/0896-6273(92)90128-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0896-6273(92)90128-z</ArticleId><ArticleId IdType="pubmed">1351731</ArticleId></ArticleIdList></Reference><Reference><Citation>Rochon D, Rousse I, Robitaille R (2001) Synapse-glia interactions at the mammalian neuromuscular junction. J Neurosci 21(11):3819&#x2013;3829. https://doi.org/10.1523/JNEUROSCI.21-11-03819.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-11-03819.2001</ArticleId><ArticleId IdType="pubmed">11356870</ArticleId><ArticleId IdType="pmc">6762689</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd KJ, Darabid H, Robitaille R (2010) Perisynaptic glia discriminate patterns of motor nerve activity and influence plasticity at the neuromuscular junction. J Neurosci 30(35):11870&#x2013;11882. https://doi.org/10.1523/JNEUROSCI.3165-10.2010</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3165-10.2010</ArticleId><ArticleId IdType="pubmed">20810906</ArticleId><ArticleId IdType="pmc">6633406</ArticleId></ArticleIdList></Reference><Reference><Citation>Duregotti E, Negro S, Scorzeto M, Zornetta I, Dickinson BC, Chang CJ, Montecucco C, Rigoni M (2015) Mitochondrial alarmins released by degenerating motor axon terminals activate perisynaptic Schwann cells. Proc Natl Acad Sci U S A 112(5):E497-505. https://doi.org/10.1073/pnas.1417108112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1417108112</ArticleId><ArticleId IdType="pubmed">25605902</ArticleId><ArticleId IdType="pmc">4321248</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang H, Tian L, Mikesh M, Lichtman JW, Thompson WJ (2014) Terminal Schwann cells participate in neuromuscular synapse remodeling during reinnervation following nerve injury. J Neurosci 34(18):6323&#x2013;6333. https://doi.org/10.1523/JNEUROSCI.4673-13.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4673-13.2014</ArticleId><ArticleId IdType="pubmed">24790203</ArticleId><ArticleId IdType="pmc">4004816</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour D, Tremblay E, Martineau &#xc9;, Julien JP, Robitaille R (2015) Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J Neurosci 35(2):688&#x2013;706. https://doi.org/10.1523/JNEUROSCI.1379-14.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1379-14.2015</ArticleId><ArticleId IdType="pubmed">25589763</ArticleId><ArticleId IdType="pmc">6605374</ArticleId></ArticleIdList></Reference><Reference><Citation>Carrasco DI, Seburn KL, Pinter MJ (2016) Altered terminal Schwann cell morphology precedes denervation in SOD1 mice. Exp Neurol 275(Pt 1):172&#x2013;181. https://doi.org/10.1016/j.expneurol.2015.09.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2015.09.014</ArticleId><ArticleId IdType="pubmed">26416261</ArticleId></ArticleIdList></Reference><Reference><Citation>De Winter F, Vo T, Stam FJ, Wisman LAB, B&#xe4;r PR, Niclou SP, van Muiswinkel FL, Verhaagen J (2006) The expression of the chemorepellent semaphorin 3A is selectively induced in terminal schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 32(1&#x2013;2):102&#x2013;117. https://doi.org/10.1016/j.mcn.2006.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2006.03.002</ArticleId><ArticleId IdType="pubmed">16677822</ArticleId></ArticleIdList></Reference><Reference><Citation>Nascimento F, Sebasti&#xe3;o AM, Ribeiro JA (2015) Presymptomatic and symptomatic ALS SOD1(G93A) mice differ in adenosine A1 and A2A receptor-mediated tonic modulation of neuromuscular transmission. Purinergic Signal 11(4):471&#x2013;480. https://doi.org/10.1007/s11302-015-9465-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11302-015-9465-4</ArticleId><ArticleId IdType="pubmed">26335190</ArticleId><ArticleId IdType="pmc">4648802</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrov D, Mansfield C, Moussy A, Hermine O (2017) ALS clinical trials review: 20 years of failure. are we any closer to registering a new treatment? Front Aging Neurosci 9:68. https://doi.org/10.3389/fnagi.2017.00068</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00068</ArticleId><ArticleId IdType="pubmed">28382000</ArticleId><ArticleId IdType="pmc">5360725</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JJ (2020) Overview of current and emerging therapies for amytrophic lateral sclerosis. Am J Manag Care 26(9 Suppl):S191&#x2013;S197. https://doi.org/10.37765/ajmc.2020.88483</Citation><ArticleIdList><ArticleId IdType="doi">10.37765/ajmc.2020.88483</ArticleId><ArticleId IdType="pubmed">32840332</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen QT, Parsadanian AS, Snider WD, Lichtman JW (1998) Hyperinnervation of neuromuscular junctions caused by GDNF overexpression in muscle. Science 279(5357):1725&#x2013;1729. https://doi.org/10.1126/science.279.5357.1725</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.279.5357.1725</ArticleId><ArticleId IdType="pubmed">9497292</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller-Peck CR, Feng G, Sanes JR, Yan Q, Lichtman JW, Snider WD (2001) Glial cell line-derived neurotrophic factor administration in postnatal life results in motor unit enlargement and continuous synaptic remodeling at the neuromuscular junction. J Neurosci 21(16):6136&#x2013;6146. https://doi.org/10.1523/JNEUROSCI.21-16-06136.2001</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.21-16-06136.2001</ArticleId><ArticleId IdType="pubmed">11487637</ArticleId><ArticleId IdType="pmc">6763186</ArticleId></ArticleIdList></Reference><Reference><Citation>Grundstr&#xf6;m E, Askmark H, Lindeberg J, Nygren I, Ebendal T, Aquilonius SM (1999) Increased expression of glial cell line-derived neurotrophic factor MRNA in muscle biopsies from patients with amyotrophic lateral sclerosis. J Neurol Sci 162(2):169&#x2013;173. https://doi.org/10.1016/s0022-510x(98)00333-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-510x(98)00333-5</ArticleId><ArticleId IdType="pubmed">10202982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto M, Sobue G, Yamamoto K, Terao S, Mitsuma T (1996) Expression of glial cell line-derived growth factor MRNA in the spinal cord and muscle in amyotrophic lateral sclerosis. Neurosci Lett 204(1&#x2013;2):117&#x2013;120. https://doi.org/10.1016/0304-3940(96)12342-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0304-3940(96)12342-9</ArticleId><ArticleId IdType="pubmed">8929992</ArticleId></ArticleIdList></Reference><Reference><Citation>Acsadi G, Anguelov RA, Yang H, Toth G, Thomas R, Jani A, Wang Y, Ianakova E et al (2002) Increased survival and function of SOD1 mice after glial cell-derived neurotrophic factor gene therapy. Hum Gene Ther 13(9):1047&#x2013;1059. https://doi.org/10.1089/104303402753812458</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/104303402753812458</ArticleId><ArticleId IdType="pubmed">12067438</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, Brakefield D, Pan Y, Hunter D, Myckatyn TM, Parsadanian A (2007) Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS. Exp Neurol 203(2):457&#x2013;471. https://doi.org/10.1016/j.expneurol.2006.08.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.08.028</ArticleId><ArticleId IdType="pubmed">17034790</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang LJ, Lu YY, Muramatsu S, Ikeguchi K, Fujimoto K, Okada T, Mizukami H, Matsushita T (2002) Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J Neurosci 22(16):6920&#x2013;6928. 20026668.</Citation></Reference><Reference><Citation>Suzuki M, McHugh J, Tork C, Shelley B, Klein SM, Aebischer P, Svendsen CN (2007) GDNF secreting human neural progenitor cells protect dying motor neurons but not their projection to muscle in a rat model of familial ALS. PLoS One 2(8):e689. https://doi.org/10.1371/journal.pone.0000689</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0000689</ArticleId><ArticleId IdType="pubmed">17668067</ArticleId><ArticleId IdType="pmc">1925150</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki M, McHugh J, Tork C, Shelley B, Hayes A, Bellantuono I, Aebischer P, Svendsen CN (2008) Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther 16(12):2002&#x2013;2010. https://doi.org/10.1038/mt.2008.197</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2008.197</ArticleId><ArticleId IdType="pubmed">18797452</ArticleId></ArticleIdList></Reference><Reference><Citation>Baudet C, Pozas E, Adameyko I, Andersson E, Ericson J, Ernfors P (2008) Retrograde signaling onto ret during motor nerve terminal maturation. J Neurosci 28(4):963&#x2013;975. https://doi.org/10.1523/JNEUROSCI.4489-07.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4489-07.2008</ArticleId><ArticleId IdType="pubmed">18216204</ArticleId><ArticleId IdType="pmc">6671002</ArticleId></ArticleIdList></Reference><Reference><Citation>Airaksinen MS, Saarma M (2002) The GDNF family: signalling, biological functions and therapeutic value. Nat Rev Neurosci 3(5):383&#x2013;394. https://doi.org/10.1038/nrn812</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn812</ArticleId><ArticleId IdType="pubmed">11988777</ArticleId></ArticleIdList></Reference><Reference><Citation>Soler RM, Dolcet X, Encinas M, Egea J, Bayascas JR, Comella JX (1999) Receptors of the glial cell line-derived neurotrophic factor family of neurotrophic factors signal cell survival through the phosphatidylinositol 3-kinase pathway in spinal cord motoneurons. J Neurosci 19(21):9160&#x2013;9169. https://doi.org/10.1523/JNEUROSCI.19-21-09160.1999</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.19-21-09160.1999</ArticleId><ArticleId IdType="pubmed">10531419</ArticleId><ArticleId IdType="pmc">6782931</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, McLennan IS, Koishi K, Hendry IA (2000) Transforming growth factor-beta 2 is anterogradely and retrogradely transported in motoneurons and up-regulated after nerve injury. Neuroscience 97(4):735&#x2013;742. https://doi.org/10.1016/s0306-4522(00)00084-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0306-4522(00)00084-1</ArticleId><ArticleId IdType="pubmed">10842018</ArticleId></ArticleIdList></Reference><Reference><Citation>Si Y, Kim S, Cui X, Zheng L, Oh SJ, Anderson T, AlSharabati M, Kazamel M et al (2015) Transforming growth factor beta (TGF-&#x3b2;) is a muscle biomarker of disease progression in ALS and correlates with Smad expression. PLoS One 10(9):e0138425. https://doi.org/10.1371/journal.pone.0138425</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0138425</ArticleId><ArticleId IdType="pubmed">26375954</ArticleId><ArticleId IdType="pmc">4574401</ArticleId></ArticleIdList></Reference><Reference><Citation>Duque T, Gromicho M, Pronto-Laborinho AC, de Carvalho M (2020) Transforming growth factor-&#x3b2; plasma levels and its role in amyotrophic lateral sclerosis. Med Hypotheses 139:109632. https://doi.org/10.1016/j.mehy.2020.109632</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.109632</ArticleId><ArticleId IdType="pubmed">32085981</ArticleId></ArticleIdList></Reference><Reference><Citation>Peters S, Zitzelsperger E, Kuespert S, Iberl S, Heydn R, Johannesen S, Petri S, Aigner L et al (2017) The TGF-&#x3b2; system as a potential pathogenic player in disease modulation of amyotrophic lateral sclerosis. Front Neurol 8:669. https://doi.org/10.3389/fneur.2017.00669</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2017.00669</ArticleId><ArticleId IdType="pubmed">29326641</ArticleId><ArticleId IdType="pmc">5736544</ArticleId></ArticleIdList></Reference><Reference><Citation>I&#x142;zecka J, Stelmasiak Z, Dobosz B (2002) Transforming growth factor-beta 1 (Tgf-Beta 1) in patients with amyotrophic lateral sclerosis. Cytokine 20(5):239&#x2013;243. https://doi.org/10.1006/cyto.2002.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/cyto.2002.2005</ArticleId><ArticleId IdType="pubmed">12550109</ArticleId></ArticleIdList></Reference><Reference><Citation>Houi K, Kobayashi T, Kato S, Mochio S, Inoue K (2002) Increased plasma TGF-Beta1 in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 106(5):299&#x2013;301. https://doi.org/10.1034/j.1600-0404.2002.01301.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1034/j.1600-0404.2002.01301.x</ArticleId><ArticleId IdType="pubmed">12371924</ArticleId></ArticleIdList></Reference><Reference><Citation>Meroni M, Crippa V, Cristofani R, Rusmini P, Cicardi ME, Messi E, Piccolella M, Tedesco B et al (2019) Transforming growth factor beta 1 signaling is altered in the spinal cord and muscle of amyotrophic lateral sclerosis mice and patients. Neurobiol Aging 82:48&#x2013;59. https://doi.org/10.1016/j.neurobiolaging.2019.07.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2019.07.001</ArticleId><ArticleId IdType="pubmed">31394426</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonzalez D, Contreras O, Rebolledo DL, Espinoza JP, van Zundert B, Brandan E (2017) ALS skeletal muscle shows enhanced TGF-&#x3b2; signaling fibrosis and induction of fibro/adipogenic progenitor markers. PLoS One 12(5):e0177649. https://doi.org/10.1371/journal.pone.0177649</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0177649</ArticleId><ArticleId IdType="pubmed">28520806</ArticleId><ArticleId IdType="pmc">5433732</ArticleId></ArticleIdList></Reference><Reference><Citation>Galbiati M, Crippa V, Rusmini P, Cristofani R, Messi E, Piccolella M, Tedesco B, Ferrari V et al (2020) Multiple roles of transforming growth factor beta in amyotrophic lateral sclerosis. Int J Mol Sci 21(12):E4291. https://doi.org/10.3390/ijms21124291</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21124291</ArticleId><ArticleId IdType="pubmed">32560258</ArticleId></ArticleIdList></Reference><Reference><Citation>Taetzsch T, Tenga MJ, Valdez G (2017) Muscle fibers secrete FGFBP1 to slow degeneration of neuromuscular synapses during aging and progression of ALS. J Neurosci 37(1):70&#x2013;82. https://doi.org/10.1523/JNEUROSCI.2992-16.2016</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2992-16.2016</ArticleId><ArticleId IdType="pubmed">28053031</ArticleId><ArticleId IdType="pmc">5214636</ArticleId></ArticleIdList></Reference><Reference><Citation>Day WA, Koishi K, Nukuda H, McLennan IS (2005) Transforming growth factor-beta 2 causes an acute improvement in the motor performance of transgenic ALS mice. Neurobiol Dis 19(1&#x2013;2):323&#x2013;330. https://doi.org/10.1016/j.nbd.2005.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2005.01.010</ArticleId><ArticleId IdType="pubmed">15837588</ArticleId></ArticleIdList></Reference><Reference><Citation>Fong SW, McLennan IS, McIntyre A, Reid J, Shennan KIJ, Bewick GS (2010) TGF-Beta2 alters the characteristics of the neuromuscular junction by regulating presynaptic quantal size. Proc Natl Acad Sci U S A 107(30):13515&#x2013;13519. https://doi.org/10.1073/pnas.1001695107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1001695107</ArticleId><ArticleId IdType="pubmed">20624974</ArticleId><ArticleId IdType="pmc">2922142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng C, Sk&#xf6;ld MK, Li J, Nennesmo I, Fadeel B, Henter JI (2007) VEGF reduces astrogliosis and preserves neuromuscular junctions in ALS transgenic mice. Biochem Biophys Res Commun 363(4):989&#x2013;993. https://doi.org/10.1016/j.bbrc.2007.09.088</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2007.09.088</ArticleId><ArticleId IdType="pubmed">17923114</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, Carmeliet P, Mazarakis ND (2004) VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 429(6990):413&#x2013;417. https://doi.org/10.1038/nature02544</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature02544</ArticleId><ArticleId IdType="pubmed">15164063</ArticleId></ArticleIdList></Reference><Reference><Citation>Krakora D, Mulcrone P, Meyer M, Lewis C, Bernau K, Gowing G, Zimprich C, Aebischer P et al (2013) Synergistic effects of GDNF and VEGF on lifespan and disease progression in a familial ALS rat model. Mol Ther 21(8):1602&#x2013;1610. https://doi.org/10.1038/mt.2013.108</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2013.108</ArticleId><ArticleId IdType="pubmed">23712039</ArticleId><ArticleId IdType="pmc">3734670</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Aleman I, Barrios V, Berciano J (1998) The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 50(3):772&#x2013;776. https://doi.org/10.1212/wnl.50.3.772</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.50.3.772</ArticleId><ArticleId IdType="pubmed">9521273</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C, Serafini M, Prelle A, Magni P, Dozio E, Ruscica M, Sassone J, Colciago C et al (2012) Impaired expression of insulin-like growth factor-1 system in skeletal muscle of amyotrophic lateral sclerosis patients. Muscle Nerve 45(2):200&#x2013;208. https://doi.org/10.1002/mus.22288</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.22288</ArticleId><ArticleId IdType="pubmed">22246875</ArticleId><ArticleId IdType="pmc">3306791</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagel G, Peter RS, Rosenbohm A, Koenig W, Dupuis L, Rothenbacher D, Ludolph AC (2020) Association of insulin-like growth factor 1 concentrations with risk for and prognosis of amyotrophic lateral sclerosis - results from the ALS Registry Swabia. Sci Rep 10(1):736. https://doi.org/10.1038/s41598-020-57744-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-57744-x</ArticleId><ArticleId IdType="pubmed">31959864</ArticleId><ArticleId IdType="pmc">6971302</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaspar BK, Llad&#xf3; J, Sherkat N, Rothstein JD, Gage FH (2003) Retrograde Viral Delivery of IGF-1 Prolongs Survival in a Mouse ALS Model. Science 301(5634):839&#x2013;842. https://doi.org/10.1126/science.1086137</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1086137</ArticleId><ArticleId IdType="pubmed">12907804</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Giacinti C, Pelosi L, Nicoletti C, Winn N, Barberi L, Molinaro M, Rosenthal N et al (2005) Muscle expression of a local Igf-1 isoform protects motor neurons in an ALS mouse model. J Cell Biol 168(2):193&#x2013;199. https://doi.org/10.1083/jcb.200407021</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200407021</ArticleId><ArticleId IdType="pubmed">15657392</ArticleId><ArticleId IdType="pmc">2171577</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen D, Cui C, Duan W, Wang W, Wang Y, Liu Y, Li Z, Li C (2019) The role of insulin-like growth factor 1 in ALS cell and mouse models: a mitochondrial protector. Brain Res Bull 144:1&#x2013;13. https://doi.org/10.1016/j.brainresbull.2018.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresbull.2018.09.015</ArticleId><ArticleId IdType="pubmed">30414993</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantilla CB, Stowe JM, Sieck DC, Ermilov LG, Greising SM, Zhang C, Shokat KM (1985) Sieck GC (2014) TrkB kinase activity maintains synaptic function and structural integrity at adult neuromuscular junctions. J Appl Physiol 117(8):910&#x2013;920. https://doi.org/10.1152/japplphysiol.01386.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.01386.2013</ArticleId></ArticleIdList></Reference><Reference><Citation>Santaf&#xe9; MM, Garcia N, Tom&#xe0;s M, Obis T, Lanuza MA, Besalduch N, Tom&#xe0;s J (2014) The interaction between tropomyosin-related kinase B receptors and serine kinases modulates acetylcholine release in adult neuromuscular junctions. Neurosci Lett 561:171&#x2013;175. https://doi.org/10.1016/j.neulet.2013.12.073</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2013.12.073</ArticleId><ArticleId IdType="pubmed">24406154</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishio T, Sunohara N, Furukawa S (1998) Neutrophin switching in spinal motoneurons of amyotrophic lateral sclerosis. NeuroReport 9(7):1661&#x2013;1665. https://doi.org/10.1097/00001756-199805110-00073</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-199805110-00073</ArticleId><ArticleId IdType="pubmed">9631483</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xfc;st BM, Copray JCVM, Brouwer N, Troost D, Boddeke HWGM (2002) Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 177(2):419&#x2013;427. https://doi.org/10.1006/exnr.2002.8011</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2002.8011</ArticleId><ArticleId IdType="pubmed">12429188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutoh T, Sobue G, Hamano T, Kuriyama M, Hirayama M, Yamamoto M, Mitsuma T (2000) Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis. Neurochem Res 25(2):239&#x2013;245. https://doi.org/10.1023/a:1007575504321</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1007575504321</ArticleId><ArticleId IdType="pubmed">10786708</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Tian D, Li J, Chen L, Tang L, Fan D (2017) The analysis of two BDNF polymorphisms G196A/C270T in Chinese sporadic amyotrophic lateral sclerosis. Front Aging Neurosci 9:135. https://doi.org/10.3389/fnagi.2017.00135</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00135</ArticleId><ArticleId IdType="pubmed">28539884</ArticleId><ArticleId IdType="pmc">5423950</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borr&#xe0;s L, Hurtado E, Cilleros-Ma&#xf1;&#xe9; V, Biondi O, Charbonnier F, Tom&#xe0;s M, Garcia N, Lanuza MA et al (2019) Overview of impaired BDNF signaling their coupled downstream serine-threonine kinases and SNARE/SM complex in the neuromuscular junction of the amyotrophic lateral sclerosis model SOD1-G93A Mice. Mol Neurobiol 56(10):6856&#x2013;6872. https://doi.org/10.1007/s12035-019-1550-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1550-1</ArticleId><ArticleId IdType="pubmed">30929165</ArticleId></ArticleIdList></Reference><Reference><Citation>Just-Borr&#xe0;s L, Hurtado E, Cilleros-Ma&#xf1;&#xe9; V, Biondi O, Charbonnier F, Tom&#xe0;s M, Garcia N, Tom&#xe0;s J et al (2020) Running and swimming prevent the deregulation of the BDNF/TrkB neurotrophic signalling at the neuromuscular junction in mice with amyotrophic lateral sclerosis. Cell Mol Life Sci 77(15):3027&#x2013;3040. https://doi.org/10.1007/s00018-019-03337-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03337-5</ArticleId><ArticleId IdType="pubmed">31646358</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijayalakshmi K, Alladi PA, Sathyaprabha TN, Subramaniam JR, Nalini A, Raju TR (2009) Cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients induces degeneration of a cultured motor neuron cell line. Brain Res 1263:122&#x2013;133. https://doi.org/10.1016/j.brainres.2009.01.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2009.01.041</ArticleId><ArticleId IdType="pubmed">19368830</ArticleId></ArticleIdList></Reference><Reference><Citation>Shruthi S, Sumitha R, Varghese AM, Ashok S, Chandrasekhar Sagar BK, Sathyaprabha TN, Nalini A, Kramer BW et al (2017) Brain-derived neurotrophic factor facilitates functional recovery from ALS-cerebral spinal fluid-induced neurodegenerative changes in the NSC-34 motor neuron cell line. Neurodegener Dis 17(1):44&#x2013;58. https://doi.org/10.1159/000447559</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000447559</ArticleId><ArticleId IdType="pubmed">27617773</ArticleId></ArticleIdList></Reference><Reference><Citation>Deepa P, Shahani N, Alladi PA, Vijayalakshmi K, Sathyaprabha TN, Nalini A, Ravi V, Raju TR (2011) Down regulation of trophic factors in neonatal rat spinal cord after administration of cerebrospinal fluid from sporadic amyotrophic lateral sclerosis patients. J Neural Transm (Vienna) 118(4):531&#x2013;538. https://doi.org/10.1007/s00702-010-0520-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-010-0520-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovanda A, Leonardis L, Zidar J, Koritnik B, Dolenc-Groselj L, Ristic Kovacic S, Curk T, Rogelj B (2018) Differential expression of microRNAs and other small RNAs in muscle tissue of patients with ALS and healthy age-matched controls. Sci Rep 8(1):5609. https://doi.org/10.1038/s41598-018-23139-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-23139-2</ArticleId><ArticleId IdType="pubmed">29618798</ArticleId><ArticleId IdType="pmc">5884852</ArticleId></ArticleIdList></Reference><Reference><Citation>Dardiotis E, Aloizou AM, Siokas V, Patrinos GP, Deretzi G, Mitsias P, Aschner M, Tsatsakis A (2018) The role of MicroRNAs in patients with amyotrophic lateral sclerosis. J Mol Neurosci 66(4):617&#x2013;628. https://doi.org/10.1007/s12031-018-1204-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-018-1204-1</ArticleId><ArticleId IdType="pubmed">30415446</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell AP, Wada S, Vergani L, Hock MB, Lamon S, L&#xe9;ger B, Ushida T, Cartoni R et al (2013) Disruption of skeletal muscle mitochondrial network genes and MiRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 49:107&#x2013;117. https://doi.org/10.1016/j.nbd.2012.08.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2012.08.015</ArticleId><ArticleId IdType="pubmed">22975021</ArticleId></ArticleIdList></Reference><Reference><Citation>Emde A, Eitan C, Liou L, Libby RT, Rivkin N, Magen I, Reichenstein I, Oppenheim H et al (2015) Dysregulated MiRNA biogenesis downstream of cellular stress and ALS-causing mutations: a new mechanism for ALS. EMBO J 34(21):2633&#x2013;2651. https://doi.org/10.15252/embj.201490493</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201490493</ArticleId><ArticleId IdType="pubmed">26330466</ArticleId><ArticleId IdType="pmc">4641530</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JF, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang DZ (2006) The role of MicroRNA-1 and MicroRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 38(2):228&#x2013;233. https://doi.org/10.1038/ng1725</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1725</ArticleId><ArticleId IdType="pubmed">16380711</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen JF, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang DZ (2010) MicroRNA-1 and MicroRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 190(5):867&#x2013;879. https://doi.org/10.1083/jcb.200911036</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200911036</ArticleId><ArticleId IdType="pubmed">20819939</ArticleId><ArticleId IdType="pmc">2935565</ArticleId></ArticleIdList></Reference><Reference><Citation>Pegoraro V, Merico A, Angelini C (2017) Micro-RNAs in ALS muscle: differences in gender age at onset and disease duration. J Neurol Sci 380:58&#x2013;63. https://doi.org/10.1016/j.jns.2017.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2017.07.008</ArticleId><ArticleId IdType="pubmed">28870590</ArticleId><ArticleId IdType="pmc">5598142</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, Bernardini C, Martini M, Baranzini M, Barba M, Musar&#xf2; A (2015) Muscle Expression of SOD1(G93A) Modulates MicroRNA and MRNA transcription pattern associated with the myelination process in the spinal cord of transgenic mice. Front Cell Neurosci 9:463. https://doi.org/10.3389/fncel.2015.00463</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00463</ArticleId><ArticleId IdType="pubmed">26648847</ArticleId><ArticleId IdType="pmc">4664730</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez G, Heyer MP, Feng G, Sanes JR (2014) The role of muscle MicroRNAs in repairing the neuromuscular junction. PLoS One 9(3):e93140. https://doi.org/10.1371/journal.pone.0093140</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0093140</ArticleId><ArticleId IdType="pubmed">24664281</ArticleId><ArticleId IdType="pmc">3963997</ArticleId></ArticleIdList></Reference><Reference><Citation>Maimon R, Ionescu A, Bonnie A, Sweetat S, Wald-Altman S, Inbar S, Gradus T, Trotti D et al (2018) MiR126-5p downregulation facilitates axon degeneration and NMJ disruption via a non-cell-autonomous mechanism in ALS. J Neurosci 38(24):5478&#x2013;5494. https://doi.org/10.1523/JNEUROSCI.3037-17.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.3037-17.2018</ArticleId><ArticleId IdType="pubmed">29773756</ArticleId><ArticleId IdType="pmc">6001038</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR et al (2009) MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 326(5959):1549&#x2013;1554. https://doi.org/10.1126/science.1181046</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1181046</ArticleId><ArticleId IdType="pubmed">20007902</ArticleId><ArticleId IdType="pmc">2796560</ArticleId></ArticleIdList></Reference><Reference><Citation>Toivonen JM, Manzano R, Oliv&#xe1;n S, Zaragoza P, Garc&#xed;a-Redondo A, Osta R (2014) MicroRNA-206: A potential circulating biomarker candidate for amyotrophic lateral sclerosis. PLoS One 9(2):e89065. https://doi.org/10.1371/journal.pone.0089065</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089065</ArticleId><ArticleId IdType="pubmed">24586506</ArticleId><ArticleId IdType="pmc">3930686</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten SA, Aggad D, Martinez J, Tremblay E, Petrillo J, Armstrong GA, La Fontaine A, Maios C et al (2017) Neuroleptics as therapeutic compounds stabilizing neuromuscular transmission in amyotrophic lateral sclerosis. JCI Insight 2:(22). https://doi.org/10.1172/jci.insight.97152 .</Citation></Reference><Reference><Citation>Pozzi S, Thammisetty SS, Julien JP (2018) Chronic administration of pimozide fails to attenuate motor and pathological deficits in two mouse models of amyotrophic lateral sclerosis. Neurotherapeutics 15(3):715&#x2013;727. https://doi.org/10.1007/s13311-018-0634-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-018-0634-3</ArticleId><ArticleId IdType="pubmed">29790082</ArticleId><ArticleId IdType="pmc">6095790</ArticleId></ArticleIdList></Reference><Reference><Citation>Bose P, Tremblay E, Maois C, Narasimhan V, Armstrong GAB, Liao M, Parker JA, Robitaille R et al (2019) The novel small molecule TRVA242 stabilizes neuromuscular junction defects in multiple animal models of amyotrophic lateral sclerosis. Neurotherapeutics 16(4):1149&#x2013;1166. https://doi.org/10.1007/s13311-019-00765-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-019-00765-w</ArticleId><ArticleId IdType="pubmed">31342410</ArticleId><ArticleId IdType="pmc">6985319</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vande Velde C, Cleveland DW (2006) ALS: A disease of motor neurons and their nonneuronal neighbors. Neuron 52(1):39&#x2013;59. https://doi.org/10.1016/j.neuron.2006.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio FP, Carrasco MA, Siao MC, Maniatis T, Eggan K (2007) Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS Model. Nat Neurosci 10(5):608&#x2013;614. https://doi.org/10.1038/nn1885</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId><ArticleId IdType="pmc">3139463</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, Przedborski S (2007) Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci 10(5):615&#x2013;622. https://doi.org/10.1038/nn1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId><ArticleId IdType="pmc">3799799</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats A, Gourie-Devi M, Ahuja K, Sharma A, Wajid S, Ganguly NK, Taneja V (2018) Expression analysis of protein homeostasis pathways in the peripheral blood mononuclear cells of sporadic amyotrophic lateral sclerosis patients. J Neurol Sci 387:85&#x2013;91. https://doi.org/10.1016/j.jns.2018.01.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2018.01.035</ArticleId><ArticleId IdType="pubmed">29571878</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu JX, Br&#xe4;nnstr&#xf6;m T, Andersen PM, Pedrosa-Domell&#xf6;f F (2011) Different impact of ALS on laminin isoforms in human extraocular muscles versus limb muscles. Invest Ophthalmol Vis Sci 52(7):4842&#x2013;4852. https://doi.org/10.1167/iovs.10-7132</Citation><ArticleIdList><ArticleId IdType="doi">10.1167/iovs.10-7132</ArticleId><ArticleId IdType="pubmed">21372009</ArticleId></ArticleIdList></Reference><Reference><Citation>Charcot J, Joffroy A (1869) Deux cas d&#x2019;atrophie musculaire progressive avec lesion de la substance grise et des faisceaux antero-lateraux de la moelle epiniere. Arch Physiol Neurol Pathol 2:744&#x2013;754</Citation></Reference><Reference><Citation>Prout AJ, Eisen AA (1994) The cortical silent period and amyotrophic lateral sclerosis. Muscle Nerve 17(2):217&#x2013;223. https://doi.org/10.1002/mus.880170213</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880170213</ArticleId><ArticleId IdType="pubmed">8114792</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills KR (1995) Motor neuron disease. studies of the corticospinal excitation of single motor neurons by magnetic brain stimulation. Brain 118(Pt 4):971&#x2013;982. https://doi.org/10.1093/brain/118.4.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/118.4.971</ArticleId><ArticleId IdType="pubmed">7655892</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisen A, Weber M (2001) The motor cortex and amyotrophic lateral sclerosis. Muscle Nerve 24(4):564&#x2013;573. https://doi.org/10.1002/mus.1042</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.1042</ArticleId><ArticleId IdType="pubmed">11268031</ArticleId></ArticleIdList></Reference><Reference><Citation>Vucic S, Cheah BC, Yiannikas C, Kiernan MC (2011) Cortical excitability distinguishes ALS from mimic disorders. Clin Neurophysiol 122(9):1860&#x2013;1866. https://doi.org/10.1016/j.clinph.2010.12.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2010.12.062</ArticleId><ArticleId IdType="pubmed">21382747</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Kiernan MC, Vucic S (2014) Cortical dysfunction underlies the development of the split-hand in amyotrophic lateral sclerosis. PLoS One 9(1):e87124. https://doi.org/10.1371/journal.pone.0087124</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0087124</ArticleId><ArticleId IdType="pubmed">24475241</ArticleId><ArticleId IdType="pmc">3901749</ArticleId></ArticleIdList></Reference><Reference><Citation>Geevasinga N, Menon P, &#xd6;zdinler PH, Kiernan MC, Vucic S (2016) Pathophysiological and diagnostic implications of cortical dysfunction in ALS. Nat Rev Neurol 12(11):651&#x2013;661. https://doi.org/10.1038/nrneurol.2016.140</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.140</ArticleId><ArticleId IdType="pubmed">27658852</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon P, Geevasinga N, van den Bos M, Yiannikas C, Kiernan MC, Vucic S (2017) Cortical hyperexcitability and disease spread in amyotrophic lateral sclerosis. Eur J Neurol 24(6):816&#x2013;824. https://doi.org/10.1111/ene.13295</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.13295</ArticleId><ArticleId IdType="pubmed">28436181</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>